☰

Peter Palese - Publications

Affiliations: 
Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
Microbiology Biology
Tree Info Similar researchers PubMed Report error

470 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Van Reeth K, Parys A, Gracia JCM, Trus I, Chiers K, Meade P, Liu S, Palese P, Krammer F, Vandoorn E. Sequential vaccinations with divergent H1N1 influenza virus strains induce multi-H1 clade neutralizing antibodies in swine. Nature Communications. 14: 7745. PMID 38008801 DOI: 10.1038/s41467-023-43339-3  0.459
2023 Edgar JE, Trezise S, Anthony RM, Krammer F, Palese P, Ravetch JV, Bournazos S. Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcγR-dependent protection in vivo. Proceedings of the National Academy of Sciences of the United States of America. 120: e2314905120. PMID 37871218 DOI: 10.1073/pnas.2314905120  0.496
2023 Puente-Massaguer E, Vasilev K, Beyer A, Loganathan M, Francis B, Scherm MJ, Arunkumar GA, González-Domínguez I, Zhu X, Wilson IA, Coughlan L, Sun W, Palese P, Krammer F. Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice. Science Advances. 9: eadi4753. PMID 37703367 DOI: 10.1126/sciadv.adi4753  0.455
2023 Puente-Massaguer E, Beyer A, Loganathan M, Sapse I, Carreño JM, Bajic G, Sun W, Palese P, Krammer F. Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses. Frontiers in Bioengineering and Biotechnology. 11: 1097349. PMID 37342504 DOI: 10.3389/fbioe.2023.1097349  0.532
2023 Sánchez-de Prada L, Sanz-Muñoz I, Sun W, Palese P, Ortiz de Lejarazu R, Eiros JM, García-Sastre A, Aydillo T. Group 1 and group 2 hemagglutinin stalk antibody response according to age. Frontiers in Immunology. 14: 1194073. PMID 37313413 DOI: 10.3389/fimmu.2023.1194073  0.452
2023 Ponce-de-León S, Torres M, Soto-Ramírez LE, Calva JJ, Santillán-Doherty P, Carranza-Salazar DE, Carreño JM, Carranza C, Juárez E, Carreto-Binaghi LE, Ramírez-Martínez L, Paz De la Rosa G, Vigueras-Moreno R, Ortiz-Stern A, López-Vidal Y, ... ... Palese P, et al. Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico. Npj Vaccines. 8: 67. PMID 37164959 DOI: 10.1038/s41541-023-00662-6  0.327
2023 Widge AT, Hofstetter AR, Houser KV, Awan SF, Chen GL, Burgos Florez MC, Berkowitz NM, Mendoza F, Hendel CS, Holman LA, Gordon IJ, Apte P, Liang CJ, Gaudinski MR, Coates EE, ... ... Palese P, et al. An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults. Science Translational Medicine. 15: eade4790. PMID 37075129 DOI: 10.1126/scitranslmed.ade4790  0.393
2023 Carreño JM, Raskin A, Singh G, Tcheou J, Kawabata H, Gleason C, Srivastava K, Vigdorovich V, Dambrauskas N, Gupta SL, González Domínguez I, Martinez JL, Slamanig S, Sather DN, Raghunandan R, ... ... Palese P, et al. An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination. Science Translational Medicine. 15: eabo2847. PMID 36791207 DOI: 10.1126/scitranslmed.abo2847  0.353
2022 Meade P, Strohmeier S, Bermúdez-González MC, García-Sastre A, Palese P, Simon V, Krammer F. Antigenic Landscape Analysis of Individuals Vaccinated with a Universal Influenza Virus Vaccine Candidate Reveals Induction of Cross-Subtype Immunity. Journal of Virology. e0107022. PMID 36533948 DOI: 10.1128/jvi.01070-22  0.581
2022 Aydillo T, Gonzalez-Reiche AS, Stadlbauer D, Amper MA, Nair VD, Mariottini C, Sealfon SC, van Bakel H, Palese P, Krammer F, García-Sastre A. Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination. Npj Vaccines. 7: 160. PMID 36496417 DOI: 10.1038/s41541-022-00583-w  0.387
2022 González-Domínguez I, Martínez JL, Slamanig S, Lemus N, Liu Y, Lai TY, Carreño JM, Singh G, Singh G, Schotsaert M, Mena I, McCroskery S, Coughlan L, Krammer F, García-Sastre A, ... Palese P, et al. Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice. Microbiology Spectrum. e0153822. PMID 35658571 DOI: 10.1128/spectrum.01538-22  0.359
2022 Duc Dang A, Dinh Vu T, Hai Vu H, Thanh Ta V, Thi Van Pham A, Thi Ngoc Dang M, Van Le B, Huu Duong T, Van Nguyen D, Lawpoolsri S, Chinwangso P, McLellan JS, Hsieh CL, Garcia-Sastre A, Palese P, et al. Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam. Vaccine. PMID 35577631 DOI: 10.1016/j.vaccine.2022.04.078  0.301
2022 Folschweiller N, Vanden Abeele C, Chu L, Van Damme P, García-Sastre A, Krammer F, Nachbagauer R, Palese P, Solórzano A, Bi D, David MP, Friel D, Innis BL, Koch J, Mallett CP, et al. Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial. The Lancet. Infectious Diseases. PMID 35461522 DOI: 10.1016/S1473-3099(22)00024-X  0.451
2022 González-Domínguez I, Martínez JL, Slamanig S, Lemus N, Liu Y, Lai TY, Carreño JM, Singh G, Singh G, Schotsaert M, Mena I, McCroskery S, Coughlan L, Krammer F, García-Sastre A, ... Palese P, et al. Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice. Biorxiv : the Preprint Server For Biology. PMID 35350201 DOI: 10.1101/2022.03.21.485247  0.336
2022 Pitisuttithum P, Luvira V, Lawpoolsri S, Muangnoicharoen S, Kamolratanakul S, Sivakorn C, Narakorn P, Surichan S, Prangpratanporn S, Puksuriwong S, Lamola S, Mercer LD, Raghunandan R, Sun W, Liu Y, ... ... Palese P, et al. Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial. Eclinicalmedicine. 45: 101323. PMID 35284808 DOI: 10.1016/j.eclinm.2022.101323  0.37
2022 Ponce-de-León S, Torres M, Soto-Ramírez LE, José Calva J, Santillán-Doherty P, Carranza-Salazar DE, Carreño JM, Carranza C, Juárez E, Carreto-Binaghi LE, Ramírez-Martínez L, la Rosa GP, Vigueras-Moreno R, Ortiz-Stern A, López-Vidal Y, ... ... Palese P, et al. Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico. Medrxiv : the Preprint Server For Health Sciences. PMID 35169806 DOI: 10.1101/2022.02.08.22270676  0.35
2022 Houser KV, Chen GL, Carter C, Crank MC, Nguyen TA, Burgos Florez MC, Berkowitz NM, Mendoza F, Hendel CS, Gordon IJ, Coates EE, Vazquez S, Stein J, Case CL, Lawlor H, ... ... Palese P, et al. Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial. Nature Medicine. PMID 35115706 DOI: 10.1038/s41591-021-01660-8  0.37
2022 Bliss CM, Freyn AW, Caniels TG, Leyva-Grado VH, Nachbagauer R, Sun W, Tan GS, Gillespie VL, McMahon M, Krammer F, Hill AV, Palese P, Coughlan L. A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 34999208 DOI: 10.1016/j.ymthe.2022.01.011  0.551
2021 Guthmiller JJ, Han J, Utset HA, Li L, Lan LY, Henry C, Stamper CT, McMahon M, O'Dell G, Fernández-Quintero ML, Freyn AW, Amanat F, Stovicek O, Gentles L, Richey ST, ... ... Palese P, et al. Broadly neutralizing antibodies target a hemagglutinin anchor epitope. Nature. PMID 34942633 DOI: 10.1038/s41586-021-04356-8  0.585
2021 Tcheou J, Raskin A, Singh G, Kawabata H, Bielak D, Sun W, González-Domínguez I, Sather DN, García-Sastre A, Palese P, Krammer F, Carreño JM. Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats. Frontiers in Immunology. 12: 791764. PMID 34868082 DOI: 10.3389/fimmu.2021.791764  0.357
2021 Rathnasinghe R, Salvatore M, Zheng H, Jangra S, Kehrer T, Mena I, Schotsaert M, Muster T, Palese P, García-Sastre A. Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1. Scientific Reports. 11: 22164. PMID 34773048 DOI: 10.1038/s41598-021-01780-8  0.664
2021 Sun W, Liu Y, Amanat F, González-Domínguez I, McCroskery S, Slamanig S, Coughlan L, Rosado V, Lemus N, Jangra S, Rathnasinghe R, Schotsaert M, Martinez JL, Sano K, Mena I, ... ... Palese P, et al. A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses. Nature Communications. 12: 6197. PMID 34707161 DOI: 10.1038/s41467-021-26499-y  0.385
2021 Tseng YY, Kuan CY, Mibayashi M, Chen CJ, Palese P, Albrecht RA, Hsu WL. Interaction between NS1 and Cellular MAVS Contributes to NS1 Mitochondria Targeting. Viruses. 13. PMID 34696339 DOI: 10.3390/v13101909  0.361
2021 Liu Y, Strohmeier S, González-Domínguez I, Tan J, Simon V, Krammer F, García-Sastre A, Palese P, Sun W. Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice. Frontiers in Immunology. 12: 746447. PMID 34603333 DOI: 10.3389/fimmu.2021.746447  0.593
2021 Pitisuttithum P, Luvira V, Lawpoolsri S, Muangnoicharoen S, Kamolratanakul S, Sivakorn C, Narakorn P, Surichan S, Prangpratanporn S, Puksuriwong S, Lamola S, Mercer LD, Raghunandan R, Sun W, Liu Y, ... ... Palese P, et al. Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial. Medrxiv : the Preprint Server For Health Sciences. PMID 34580673 DOI: 10.1101/2021.09.17.21263758  0.378
2021 Lara-Puente JH, Carreño JM, Sun W, Suárez-Martínez A, Ramírez-Martínez L, Quezada-Monroy F, Paz-De la Rosa G, Vigueras-Moreno R, Singh G, Rojas-Martínez O, Chagoya-Cortés HE, Sarfati-Mizrahi D, Soto-Priante E, López-Macías C, Krammer F, ... ... Palese P, et al. Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs. Mbio. e0190821. PMID 34544278 DOI: 10.1128/mBio.01908-21  0.324
2021 Freyn AW, Pine M, Rosado VC, Benz M, Muramatsu H, Beattie M, Tam YK, Krammer F, Palese P, Nachbagauer R, McMahon M, Pardi N. Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice. Molecular Therapy. Methods & Clinical Development. 22: 84-95. PMID 34485597 DOI: 10.1016/j.omtm.2021.06.003  0.546
2021 Rathnasinghe R, Salvatore M, Zheng H, Jangra S, Kehrer T, Mena I, Schotsaert M, Muster T, Palese P, Garcia-Sastre A. Prophylactic Protection Against Respiratory Viruses Conferred by a Prototype Live Attenuated Influenza Virus Vaccine. Research Square. PMID 34401874 DOI: 10.21203/rs.3.rs-668116/v1  0.663
2021 Guthmiller JJ, Utset HA, Henry C, Li L, Zheng NY, Sun W, Costa Vieira M, Zost S, Huang M, Hensley SE, Cobey S, Palese P, Wilson PC. An Egg-Derived Sulfated -Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines. Mbio. e0083821. PMID 34126773 DOI: 10.1128/mBio.00838-21  0.466
2021 Guthmiller JJ, Han J, Li L, Freyn AW, Liu STH, Stovicek O, Stamper CT, Dugan HL, Tepora ME, Utset HA, Bitar DJ, Hamel NJ, Changrob S, Zheng NY, Huang M, ... ... Palese P, et al. First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes. Science Translational Medicine. 13. PMID 34078743 DOI: 10.1126/scitranslmed.abg4535  0.517
2021 Rathnasinghe R, Salvatore M, Zheng H, Jangra S, Kehrer T, Mena I, Schotsaert M, Muster T, Palese P, García-Sastre A. Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine. Biorxiv : the Preprint Server For Biology. PMID 33948589 DOI: 10.1101/2021.04.28.441797  0.663
2021 Freyn AW, Han J, Guthmiller JJ, Bailey MJ, Neu K, Turner HL, Rosado VC, Chromikova V, Huang M, Strohmeier S, Liu STH, Simon V, Krammer F, Ward AB, Palese P, et al. Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33593910 DOI: 10.1073/pnas.2018102118  0.603
2021 Liu WC, Nachbagauer R, Stadlbauer D, Strohmeier S, Solórzano A, Berlanda-Scorza F, Innis BL, García-Sastre A, Palese P, Krammer F, Albrecht RA. Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model. Vaccines. 9. PMID 33440898 DOI: 10.3390/vaccines9010040  0.6
2020 Sun W, McCroskery S, Liu WC, Leist SR, Liu Y, Albrecht RA, Slamanig S, Oliva J, Amanat F, Schäfer A, Dinnon KH, Innis BL, García-Sastre A, Krammer F, Baric RS, ... Palese P, et al. A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine. Vaccines. 8. PMID 33348607 DOI: 10.3390/vaccines8040771  0.394
2020 Carreño JM, Strohmeier S, Kirkpatrick Roubidoux E, Hai R, Palese P, Krammer F. H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model. Mbio. 11. PMID 33323511 DOI: 10.1128/mBio.02090-20  0.716
2020 Nachbagauer R, Feser J, Naficy A, Bernstein DI, Guptill J, Walter EB, Berlanda-Scorza F, Stadlbauer D, Wilson PC, Aydillo T, Behzadi MA, Bhavsar D, Bliss C, Capuano C, Carreño JM, ... ... Palese P, et al. A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial. Nature Medicine. PMID 33288923 DOI: 10.1038/s41591-020-1118-7  0.443
2020 Sun W, Leist SR, McCroskery S, Liu Y, Slamanig S, Oliva J, Amanat F, Schäfer A, Dinnon KH, García-Sastre A, Krammer F, Baric RS, Palese P. Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate. Ebiomedicine. 62: 103132. PMID 33232870 DOI: 10.1016/j.ebiom.2020.103132  0.583
2020 Guthmiller JJ, Lan LY, Fernández-Quintero ML, Han J, Utset HA, Bitar DJ, Hamel NJ, Stovicek O, Li L, Tepora M, Henry C, Neu KE, Dugan HL, Borowska MT, Chen YQ, ... ... Palese P, et al. Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses. Immunity. PMID 33096040 DOI: 10.1016/j.immuni.2020.10.005  0.521
2020 Sun W, McCroskery S, Liu WC, Leist SR, Liu Y, Albrecht RA, Slamanig S, Oliva J, Amanat F, Schaefer A, Dinnon KH, Innis BL, Garcia-Sastre A, Krammer F, Baric RS, ... Palese P, et al. A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine. Biorxiv : the Preprint Server For Biology. PMID 32766572 DOI: 10.1101/2020.07.30.229120  0.393
2020 Sun W, Leist SR, McCroskery S, Liu Y, Slamanig S, Oliva J, Amanat F, Schaefer A, Dinnon K, Garcia-Sastre A, Krammer F, Baric RS, Palese P. Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate. Biorxiv : the Preprint Server For Biology. PMID 32743571 DOI: 10.1101/2020.07.26.221861  0.485
2020 Kennedy RB, Ovsyannikova IG, Palese P, Poland GA. Current Challenges in Vaccinology. Frontiers in Immunology. 11: 1181. PMID 32670279 DOI: 10.3389/Fimmu.2020.01181  0.373
2020 Behzadi MA, Choi A, Duehr J, Feyznezhad R, Upadhyay C, Schotsaert M, Palese P, Nachbagauer R. A cross-reactive mouse monoclonal antibody against rhinovirus mediates phagocytosis in vitro. Scientific Reports. 10: 9750. PMID 32546721 DOI: 10.1038/S41598-020-66600-X  0.466
2020 Zheng A, Sun W, Xiong X, Freyn AW, Peukes J, Stromeier S, Nachbagauer R, Briggs JAG, Krammer F, Palese P. Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals. Journal of Virology. PMID 32493826 DOI: 10.1128/Jvi.00742-20  0.678
2020 Freyn AW, Ramos da Silva J, Rosado VC, Bliss CM, Pine M, Mui BL, Tam YK, Madden TD, de Souza Ferreira LC, Weissman D, Krammer F, Coughlan L, Palese P, Pardi N, Nachbagauer R. A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 32359470 DOI: 10.1016/J.Ymthe.2020.04.018  0.621
2020 Mullokandov G, Vijayakumar G, Leon P, Henry C, Wilson PC, Krammer F, Palese P, Brown BD. High-complexity extracellular barcoding using a viral hemagglutinin. Proceedings of the National Academy of Sciences of the United States of America. PMID 31988118 DOI: 10.1073/Pnas.1919182117  0.79
2019 Nachbagauer R, Salaun B, Stadlbauer D, Behzadi MA, Friel D, Rajabhathor A, Choi A, Albrecht RA, Debois M, García-Sastre A, Rouxel RN, Sun W, Palese P, Mallett CP, Innis BL, et al. Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts. Npj Vaccines. 4: 51. PMID 31839997 DOI: 10.1038/s41541-019-0147-z  0.514
2019 Vijayakumar G, McCroskery S, Palese P. Engineering Newcastle disease virus as oncolytic vector for intratumoral delivery of immune checkpoint inhibitors and immunocytokines. Journal of Virology. PMID 31694938 DOI: 10.1128/Jvi.01677-19  0.748
2019 Vijayakumar G, Palese P, Goff PH. Oncolytic Newcastle disease virus expressing a checkpoint inhibitor as a radioenhancing agent for murine melanoma. Ebiomedicine. PMID 31676387 DOI: 10.1016/J.Ebiom.2019.10.032  0.782
2019 Bernstein DI, Guptill J, Naficy A, Nachbagauer R, Berlanda-Scorza F, Feser J, Wilson PC, Solórzano A, Van der Wielen M, Walter EB, Albrecht RA, Buschle KN, Chen YQ, Claeys C, Dickey M, ... ... Palese P, et al. Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial. The Lancet. Infectious Diseases. PMID 31630990 DOI: 10.1016/S1473-3099(19)30393-7  0.738
2019 Nachbagauer R, Palese P. Is a Universal Influenza Virus Vaccine Possible? Annual Review of Medicine. PMID 31600454 DOI: 10.1146/Annurev-Med-120617-041310  0.616
2019 Sun W, Zheng A, Miller R, Krammer F, Palese P. An Inactivated Influenza Virus Vaccine Approach to Targeting the Conserved Hemagglutinin Stalk and M2e Domains. Vaccines. 7. PMID 31540436 DOI: 10.3390/Vaccines7030117  0.629
2019 Broecker F, Zheng A, Suntrongwong N, Sun W, Bailey MJ, Krammer F, Palese P. Extending the stalk enhances immunogenicity of the influenza virus neuraminidase. Journal of Virology. PMID 31375573 DOI: 10.1128/Jvi.00840-19  0.779
2019 Broecker F, Liu STH, Suntronwong N, Sun W, Bailey MJ, Nachbagauer R, Krammer F, Palese P. A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains. Npj Vaccines. 4: 31. PMID 31341648 DOI: 10.1038/s41541-019-0126-4  0.714
2019 Liu WC, Nachbagauer R, Stadlbauer D, Solórzano A, Berlanda-Scorza F, García-Sastre A, Palese P, Krammer F, Albrecht RA. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model. Frontiers in Immunology. 10: 756. PMID 31105689 DOI: 10.3389/Fimmu.2019.00756  0.606
2019 Bailey MJ, Broecker F, Freyn A, Choi A, Brown JA, Fedorova N, Simon V, Lim JK, Evans MJ, García-Sastre A, Palese P, Tan GS. Human monoclonal antibodies potently neutralize Zika virus and select for escape mutations on the lateral ridge of the envelope protein. Journal of Virology. PMID 31043537 DOI: 10.1128/Jvi.00405-19  0.698
2019 Choi A, Bouzya B, Cortés Franco KD, Stadlbauer D, Rajabhathor A, Rouxel RN, Mainil R, Van der Wielen M, Palese P, García-Sastre A, Innis BL, Krammer F, Schotsaert M, Mallett CP, Nachbagauer R. Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice. Immunohorizons. 3: 133-148. PMID 31032479 DOI: 10.4049/immunohorizons.1900022  0.543
2019 Sun W, Kirkpatrick E, Ermler M, Nachbagauer R, Broecker F, Krammer F, Palese P. Development of Influenza B Universal Vaccine Candidates using the "Mosaic" Hemagglutinin Approach. Journal of Virology. PMID 30944178 DOI: 10.1128/Jvi.00333-19  0.604
2019 Bailey MJ, Broecker F, Duehr J, Arumemi F, Krammer F, Palese P, Tan GS. Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus. Mbio. 10. PMID 30940710 DOI: 10.1128/Mbio.02861-18  0.744
2019 Krammer F, Palese P. Universal influenza virus vaccines that target the conserved hemagglutinin stalk and conserved sites in the head domain. The Journal of Infectious Diseases. PMID 30715353 DOI: 10.1093/Infdis/Jiy711  0.561
2019 Goff P, Vijayakumar G, Palese P. Oncolytic Newcastle Disease Virus Expressing a Checkpoint-Inhibiting Antibody As a Radiosensitizing Immunotherapy in a Murine Melanoma Model International Journal of Radiation Oncology*Biology*Physics. 105: E648-E649. DOI: 10.1016/j.ijrobp.2019.06.1024  0.398
2018 Bailey MJ, Duehr J, Dulin H, Broecker F, Brown JA, Arumemi FO, Bermúdez González MC, Leyva-Grado VH, Evans MJ, Simon V, Lim JK, Krammer F, Hai R, Palese P, Tan GS. Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model. Nature Communications. 9: 4560. PMID 30385750 DOI: 10.1038/S41467-018-07008-0  0.799
2018 Sun W, Kang DS, Zheng A, Liu STH, Broecker F, Simon V, Krammer F, Palese P. Antibody responses towards the major antigenic sites of influenza B virus hemagglutinin in mice, ferrets and humans. Journal of Virology. PMID 30381487 DOI: 10.1128/Jvi.01673-18  0.553
2018 Liu ST, Behzadi MA, Sun W, Freyn AW, Liu WC, Broecker F, Albrecht RA, Bouvier NM, Simon V, Nachbagauer R, Krammer F, Palese P. Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance. The Journal of Clinical Investigation. PMID 30188868 DOI: 10.1172/Jci122895  0.518
2018 Broecker F, Liu STH, Sun W, Krammer F, Simon V, Palese P. Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice. Journal of Virology. PMID 30045991 DOI: 10.1128/Jvi.01100-18  0.641
2018 Coughlan L, Palese P. Overcoming Barriers in the Path to a Universal Influenza Virus Vaccine. Cell Host & Microbe. 24: 18-24. PMID 30001520 DOI: 10.1016/J.Chom.2018.06.016  0.613
2018 Krammer F, Smith GJD, Fouchier RAM, Peiris M, Kedzierska K, Doherty PC, Palese P, Shaw ML, Treanor J, Webster RG, García-Sastre A. Influenza. Nature Reviews. Disease Primers. 4: 3. PMID 29955068 DOI: 10.1038/s41572-018-0002-y  0.539
2018 Fulton BO, Sun W, Heaton NS, Palese P. The influenza B virus hemagglutinin head domain is less tolerant to transposon mutagenesis than that of the influenza A virus. Journal of Virology. PMID 29899093 DOI: 10.1128/Jvi.00754-18  0.894
2018 Nachbagauer R, Palese P. Development of next generation hemagglutinin-based broadly protective influenza virus vaccines. Current Opinion in Immunology. 53: 51-57. PMID 29680576 DOI: 10.1016/J.Coi.2018.04.001  0.615
2018 Rajendran M, Sun W, Comella P, Nachbagauer R, Wohlbold TJ, Amanat F, Kirkpatrick E, Palese P, Krammer F. An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations. Plos One. 13: e0194830. PMID 29617394 DOI: 10.1371/Journal.Pone.0194830  0.667
2018 Hamilton JR, Vijayakumar G, Palese P. A Recombinant Antibody-Expressing Influenza Virus Delays Tumor Growth in a Mouse Model. Cell Reports. 22: 1-7. PMID 29298413 DOI: 10.1016/J.Celrep.2017.12.025  0.869
2018 Palese P. H-103 Towards a universal influenza virus vaccine Jaids Journal of Acquired Immune Deficiency Syndromes. 77: 46. DOI: 10.1097/01.qai.0000532624.18390.72  0.527
2017 Nachbagauer R, Liu WC, Choi A, Wohlbold TJ, Atlas T, Rajendran M, Solórzano A, Berlanda-Scorza F, García-Sastre A, Palese P, Albrecht RA, Krammer F. A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies. Npj Vaccines. 2: 26. PMID 29263881 DOI: 10.1038/s41541-017-0026-4  0.575
2017 Palese P. Influenza: A broadly protective antibody. Nature. 551: 310-311. PMID 29144466 DOI: 10.1038/551310A  0.6
2017 He W, Chen CJ, Mullarkey CE, Hamilton JR, Wong CK, Leon PE, Uccellini MB, Chromikova V, Henry C, Hoffman KW, Lim JK, Wilson PC, Miller MS, Krammer F, Palese P, et al. Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice. Nature Communications. 8: 846. PMID 29018261 DOI: 10.1038/S41467-017-00928-3  0.802
2017 Jacobsen H, Rajendran M, Choi A, Sjursen H, Brokstad KA, Cox RJ, Palese P, Krammer F, Nachbagauer R. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model. Mbio. 8. PMID 28928215 DOI: 10.1128/Mbio.01463-17  0.647
2017 Maamary J, Wang TT, Tan GS, Palese P, Ravetch JV. Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization. Proceedings of the National Academy of Sciences of the United States of America. PMID 28874545 DOI: 10.1073/Pnas.1707950114  0.866
2017 Wohlbold TJ, Podolsky KA, Chromikova V, Kirkpatrick E, Falconieri V, Meade P, Amanat F, Tan J, tenOever BR, Tan GS, Subramaniam S, Palese P, Krammer F. Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes. Nature Microbiology. PMID 28827718 DOI: 10.1038/S41564-017-0011-8  0.572
2017 Goff PH, Hayashi T, He W, Yao S, Cottam HB, Tan GS, Crain B, Krammer F, Messer K, Pu M, Carson DA, Palese P, Corr M. Synthetic TLR4 and TLR7 ligands work additively via MyD88 to induce protective antiviral immunity in mice. Journal of Virology. PMID 28724768 DOI: 10.1128/Jvi.01050-17  0.525
2017 Krammer F, García-Sastre A, Palese P. Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Toward a Universal Influenza Virus Vaccine: Potential Target Antigens and Critical Aspects for Vaccine Development. Cold Spring Harbor Perspectives in Biology. PMID 28663209 DOI: 10.1101/Cshperspect.A028845  0.612
2017 Fulton BO, Sachs D, Schwarz MC, Palese P, Evans MJ. Transposon mutagenesis of the Zika virus genome highlights regions essential for RNA replication and restricted for immune evasion. Journal of Virology. PMID 28515302 DOI: 10.1128/Jvi.00698-17  0.849
2017 Ermler M, Kirkpatrick E, Sun W, Hai R, Amanat F, Chromikova V, Palese P, Krammer F. Chimeric hemagglutinin constructs induce broad protection against influenza B virus challenge in the mouse model. Journal of Virology. PMID 28356526 DOI: 10.1128/Jvi.00286-17  0.788
2017 Rajendran M, Nachbagauer R, Ermler ME, Bunduc P, Amanat F, Izikson R, Cox M, Palese P, Eichelberger M, Krammer F. Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin. Mbio. 8. PMID 28325769 DOI: 10.1128/Mbio.02281-16  0.582
2017 Leyva-Grado VH, Palese P. Aerosol administration increases the efficacy of oseltamivir for the treatment of mice infected with influenza viruses. Antiviral Research. 142: 12-15. PMID 28286235 DOI: 10.1016/J.Antiviral.2017.03.002  0.603
2017 Zamarin D, Holmgaard RB, Ricca J, Plitt T, Palese P, Sharma P, Merghoub T, Wolchok JD, Allison JP. Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity. Nature Communications. 8: 14340. PMID 28194010 DOI: 10.1038/Ncomms14340  0.673
2017 Nachbagauer R, Choi A, Hirsh A, Margine I, Iida S, Barrera A, Ferres M, Albrecht RA, García-Sastre A, Bouvier NM, Ito K, Medina RA, Palese P, Krammer F. Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins. Nature Immunology. PMID 28192418 DOI: 10.1038/Ni.3684  0.884
2017 Tran E, Podolsky K, Bartesaghi A, Kuybeda O, Grandinetti G, John Wohlbold T, Tan G, Nachbagauer R, Palese P, Krammer F, Subramaniam S. Cryo-EM Tomographic Analysis of a Universal Influenza Virus Vaccine Candidate Biophysical Journal. 112: 577a. DOI: 10.1016/J.Bpj.2016.11.3105  0.619
2016 Nachbagauer R, Kinzler D, Choi A, Hirsh A, Beaulieu E, Lecrenier N, Innis BL, Palese P, Mallett CP, Krammer F. A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice. Npj Vaccines. 1. PMID 29250436 DOI: 10.1038/npjvaccines.2016.15  0.53
2016 Palese P. Profile of Charles M. Rice, Ralf F. W. Bartenschlager, and Michael J. Sofia, 2016 Lasker-DeBakey Clinical Medical Research Awardees. Proceedings of the National Academy of Sciences of the United States of America. PMID 27864510 DOI: 10.1073/Pnas.1616592113  0.402
2016 Mullarkey CE, Bailey MJ, Golubeva DA, Tan GS, Nachbagauer R, He W, Novakowski KE, Bowdish DM, Miller MS, Palese P. Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner. Mbio. 7. PMID 27703076 DOI: 10.1128/Mbio.01624-16  0.639
2016 He W, Tan GS, Mullarkey CE, Lee AJ, Lam MM, Krammer F, Henry C, Wilson PC, Ashkar AA, Palese P, Miller MS. Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus. Proceedings of the National Academy of Sciences of the United States of America. PMID 27698132 DOI: 10.1073/Pnas.1609316113  0.544
2016 Leon PE, He W, Mullarkey CE, Bailey MJ, Miller MS, Krammer F, Palese P, Tan GS. Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact. Proceedings of the National Academy of Sciences of the United States of America. PMID 27647907 DOI: 10.1073/Pnas.1613225113  0.669
2016 Henry Dunand CJ, Leon PE, Huang M, Choi A, Chromikova V, Ho IY, Tan GS, Cruz J, Hirsh A, Zheng NY, Mullarkey CE, Ennis FA, Terajima M, Treanor JJ, Topham DJ, ... ... Palese P, et al. Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection. Cell Host & Microbe. 19: 800-813. PMID 27281570 DOI: 10.1016/J.Chom.2016.05.014  0.533
2016 Tran EE, Podolsky KA, Bartesaghi A, Kuybeda O, Grandinetti G, Wohlbold TJ, Tan GS, Nachbagauer R, Palese P, Krammer F, Subramaniam S. Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate. Mbio. 7. PMID 27006464 DOI: 10.1128/Mbio.00257-16  0.5
2016 Hamilton JR, Sachs D, Lim JK, Langlois RA, Palese P, Heaton NS. Club cells surviving influenza A virus infection induce temporary nonspecific antiviral immunity. Proceedings of the National Academy of Sciences of the United States of America. PMID 27001854 DOI: 10.1073/Pnas.1522376113  0.855
2016 Heaton NS, Moshkina N, Fenouil R, Gardner TJ, Aguirre S, Shah PS, Zhao N, Manganaro L, Hultquist JF, Noel J, Sachs DH, Hamilton J, Leon PE, Chawdury A, Tripathi S, ... ... Palese P, et al. Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection. Immunity. 44: 46-58. PMID 26789921 DOI: 10.1016/J.Immuni.2015.12.017  0.877
2016 Nachbagauer R, Choi A, Izikson R, Cox MM, Palese P, Krammer F. Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans. Mbio. 7. PMID 26787832 DOI: 10.1128/Mbio.01996-15  0.591
2016 Chen CJ, Ermler ME, Tan GS, Krammer F, Palese P, Hai R. Influenza A viruses expressing intra- or inter-group chimeric hemagglutinins. Journal of Virology. PMID 26764009 DOI: 10.1128/Jvi.03060-15  0.787
2016 DiLillo DJ, Palese P, Wilson PC, Ravetch JV. Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection. The Journal of Clinical Investigation. 126: 605-10. PMID 26731473 DOI: 10.1172/Jci84428  0.506
2016 Heaton NS, Moshkina N, Fenouil R, Gardner TJ, Aguirre S, Shah PS, Zhao N, Manganaro L, Hultquist JF, Noel J, Sachs D, Hamilton J, Leon PE, Chawdury A, Tripathi S, ... ... Palese P, et al. Corrections to Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection. (Immunity 44, 46-58, January 19, 2016) Immunity. 44: 438. DOI: 10.1016/J.Immuni.2016.01.016  0.875
2015 Nachbagauer R, Miller MS, Hai R, Ryder AB, Rose JK, Palese P, García-Sastre A, Krammer F, Albrecht RA. Hemagglutinin Stalk Immunity Reduces Influenza Virus Replication and Transmission in Ferrets. Journal of Virology. 90: 3268-73. PMID 26719251 DOI: 10.1128/Jvi.02481-15  0.808
2015 Ryder AB, Nachbagauer R, Buonocore L, Palese P, Krammer F, Rose JK. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains. Journal of Virology. 90: 2544-50. PMID 26676789 DOI: 10.1128/Jvi.02598-15  0.614
2015 Andrews SF, Huang Y, Kaur K, Popova LI, Ho IY, Pauli NT, Henry Dunand CJ, Taylor WM, Lim S, Huang M, Qu X, Lee JH, Salgado-Ferrer M, Krammer F, Palese P, et al. Immune history profoundly affects broadly protective B cell responses to influenza. Science Translational Medicine. 7: 316ra192. PMID 26631631 DOI: 10.1126/Scitranslmed.Aad0522  0.543
2015 Fulton BO, Palese P, Heaton NS. Replication-Competent Influenza B Reporter Viruses as Tools for Screening Antivirals and Antibodies. Journal of Virology. 89: 12226-31. PMID 26401044 DOI: 10.1128/Jvi.02164-15  0.882
2015 Wang TT, Maamary J, Tan GS, Bournazos S, Davis CW, Krammer F, Schlesinger SJ, Palese P, Ahmed R, Ravetch JV. Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy. Cell. 162: 160-9. PMID 26140596 DOI: 10.1016/J.Cell.2015.06.026  0.812
2015 Fulton BO, Sachs D, Beaty SM, Won ST, Lee B, Palese P, Heaton NS. Mutational Analysis of Measles Virus Suggests Constraints on Antigenic Variation of the Glycoproteins. Cell Reports. 11: 1331-8. PMID 26004185 DOI: 10.1016/J.Celrep.2015.04.054  0.875
2015 White KM, De Jesus P, Chen Z, Abreu P, Barile E, Mak PA, Anderson P, Nguyen QT, Inoue A, Stertz S, Koenig R, Pellecchia M, Palese P, Kuhen K, García-Sastre A, et al. A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin Protein. Acs Infectious Diseases. 1: 98-109. PMID 25984567 DOI: 10.1021/Id500022H  0.587
2015 Kaur K, Zheng NY, Smith K, Huang M, Li L, Pauli NT, Dunand CJ, Lee JH, Morrissey M, Wu Y, Joachims ML, Munroe ME, Lau D, Qu X, Krammer F, ... ... Palese P, et al. High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination. Plos One. 10: e0125618. PMID 25951191 DOI: 10.1371/Journal.Pone.0125618  0.49
2015 Leyva-Grado VH, Tan GS, Leon PE, Yondola M, Palese P. Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies. Antimicrobial Agents and Chemotherapy. 59: 4162-72. PMID 25941218 DOI: 10.1128/Aac.00290-15  0.638
2015 Wohlbold TJ, Nachbagauer R, Xu H, Tan GS, Hirsh A, Brokstad KA, Cox RJ, Palese P, Krammer F. Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice. Mbio. 6: e02556. PMID 25759506 DOI: 10.1128/Mbio.02556-14  0.603
2015 Krammer F, Palese P. Advances in the development of influenza virus vaccines. Nature Reviews. Drug Discovery. 14: 167-82. PMID 25722244 DOI: 10.1038/Nrd4529  0.597
2015 Henry Dunand CJ, Leon PE, Kaur K, Tan GS, Zheng NY, Andrews S, Huang M, Qu X, Huang Y, Salgado-Ferrer M, Ho IY, Taylor W, Hai R, Wrammert J, Ahmed R, ... ... Palese P, et al. Preexisting human antibodies neutralize recently emerged H7N9 influenza strains. The Journal of Clinical Investigation. 125: 1255-68. PMID 25689254 DOI: 10.1172/Jci74374  0.772
2015 He W, Mullarkey CE, Duty JA, Moran TM, Palese P, Miller MS. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones. Journal of Virology. 89: 3610-8. PMID 25589655 DOI: 10.1128/Jvi.03099-14  0.641
2015 Goff PH, Hayashi T, Martínez-Gil L, Corr M, Crain B, Yao S, Cottam HB, Chan M, Ramos I, Eggink D, Heshmati M, Krammer F, Messer K, Pu M, Fernandez-Sesma A, ... Palese P, et al. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses. Journal of Virology. 89: 3221-35. PMID 25568203 DOI: 10.1128/Jvi.03337-14  0.594
2015 Riegger D, Hai R, Dornfeld D, Mänz B, Leyva-Grado V, Sánchez-Aparicio MT, Albrecht RA, Palese P, Haller O, Schwemmle M, García-Sastre A, Kochs G, Schmolke M. The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA. Journal of Virology. 89: 2241-52. PMID 25505067 DOI: 10.1128/Jvi.02406-14  0.738
2015 Krammer F, Palese P, Steel J. Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin. Current Topics in Microbiology and Immunology. 386: 301-21. PMID 25007847 DOI: 10.1007/82_2014_408  0.611
2015 Krammer F, Palese P. Erratum: Advances in the development of influenza virus vaccines Nature Reviews Drug Discovery. 14: 294-294. DOI: 10.1038/Nrd4595  0.474
2014 Tan GS, Lee PS, Hoffman RM, Mazel-Sanchez B, Krammer F, Leon PE, Ward AB, Wilson IA, Palese P. Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin. Journal of Virology. 88: 13580-92. PMID 25210195 DOI: 10.1128/Jvi.02289-14  0.626
2014 Nachbagauer R, Wohlbold TJ, Hirsh A, Hai R, Sjursen H, Palese P, Cox RJ, Krammer F. Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans. Journal of Virology. 88: 13260-8. PMID 25210189 DOI: 10.1128/Jvi.02133-14  0.708
2014 Ellebedy AH, Krammer F, Li GM, Miller MS, Chiu C, Wrammert J, Chang CY, Davis CW, McCausland M, Elbein R, Edupuganti S, Spearman P, Andrews SF, Wilson PC, García-Sastre A, ... ... Palese P, et al. Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans. Proceedings of the National Academy of Sciences of the United States of America. 111: 13133-8. PMID 25157133 DOI: 10.1073/Pnas.1414070111  0.601
2014 Heaton NS, Langlois RA, Sachs D, Lim JK, Palese P, tenOever BR. Long-term survival of influenza virus infected club cells drives immunopathology. The Journal of Experimental Medicine. 211: 1707-14. PMID 25135297 DOI: 10.1084/Jem.20140488  0.782
2014 Miller MS, Palese P. Peering into the crystal ball: influenza pandemics and vaccine efficacy. Cell. 157: 294-9. PMID 24725400 DOI: 10.1016/J.Cell.2014.03.023  0.62
2014 Zamarin D, Holmgaard RB, Subudhi SK, Park JS, Mansour M, Palese P, Merghoub T, Wolchok JD, Allison JP. Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy. Science Translational Medicine. 6: 226ra32. PMID 24598590 DOI: 10.1126/Scitranslmed.3008095  0.574
2014 Krammer F, Albrecht RA, Tan GS, Margine I, Hai R, Schmolke M, Runstadler J, Andrews SF, Wilson PC, Cox RJ, Treanor JJ, García-Sastre A, Palese P. Divergent H7 immunogens offer protection from H7N9 virus challenge. Journal of Virology. 88: 3976-85. PMID 24453375 DOI: 10.1128/Jvi.03095-13  0.871
2014 DiLillo DJ, Tan GS, Palese P, Ravetch JV. Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo. Nature Medicine. 20: 143-51. PMID 24412922 DOI: 10.1038/Nm.3443  0.486
2014 Krammer F, Hai R, Yondola M, Tan GS, Leyva-Grado VH, Ryder AB, Miller MS, Rose JK, Palese P, García-Sastre A, Albrecht RA. Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets. Journal of Virology. 88: 3432-42. PMID 24403585 DOI: 10.1128/Jvi.03004-13  0.8
2014 Krammer F, Palese P. Universal influenza virus vaccines: need for clinical trials. Nature Immunology. 15: 3-5. PMID 24352315 DOI: 10.1038/Ni.2761  0.625
2014 Krammer F, Margine I, Hai R, Flood A, Hirsh A, Tsvetnitsky V, Chen D, Palese P. H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge. Journal of Virology. 88: 2340-3. PMID 24307585 DOI: 10.1128/Jvi.03183-13  0.892
2014 Eggink D, Goff PH, Palese P. Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domain. Journal of Virology. 88: 699-704. PMID 24155380 DOI: 10.1128/Jvi.02608-13  0.582
2014 Zamarin D, Holmgaard RB, Subudhi SK, Park J, Mansour M, Palese P, Merghoub T, Wolchok JD, Allison JP. Potentiation of immune checkpoint blockade cancer immunotherapy with oncolytic virus. Journal of Clinical Oncology. 32: 3051-3051. DOI: 10.1200/Jco.2014.32.15_Suppl.3051  0.672
2013 Hai R, Schmolke M, Leyva-Grado VH, Thangavel RR, Margine I, Jaffe EL, Krammer F, Solórzano A, García-Sastre A, Palese P, Bouvier NM. Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nature Communications. 4: 2854. PMID 24326875 DOI: 10.1038/Ncomms3854  0.881
2013 Margine I, Palese P, Krammer F. Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system. Journal of Visualized Experiments : Jove. e51112. PMID 24300384 DOI: 10.3791/51112  0.871
2013 Heaton NS, Sachs D, Chen CJ, Hai R, Palese P. Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins. Proceedings of the National Academy of Sciences of the United States of America. 110: 20248-53. PMID 24277853 DOI: 10.1073/Pnas.1320524110  0.853
2013 Goff PH, Eggink D, Seibert CW, Hai R, Martínez-Gil L, Krammer F, Palese P. Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies. Plos One. 8: e79194. PMID 24223176 DOI: 10.1371/Journal.Pone.0079194  0.893
2013 Krammer F, Palese P. Influenza virus hemagglutinin stalk-based antibodies and vaccines. Current Opinion in Virology. 3: 521-30. PMID 23978327 DOI: 10.1016/J.Coviro.2013.07.007  0.669
2013 Miller MS, Gardner TJ, Krammer F, Aguado LC, Tortorella D, Basler CF, Palese P. Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. Science Translational Medicine. 5: 198ra107. PMID 23946196 DOI: 10.1126/Scitranslmed.3006637  0.641
2013 Margine I, Krammer F, Hai R, Heaton NS, Tan GS, Andrews SA, Runstadler JA, Wilson PC, Albrecht RA, García-Sastre A, Palese P. Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses. Journal of Virology. 87: 10435-46. PMID 23903831 DOI: 10.1128/Jvi.01715-13  0.876
2013 Martinez-Gil L, Alamares-Sapuay JG, Ramana Reddy MV, Goff PH, Premkumar Reddy E, Palese P. A small molecule multi-kinase inhibitor reduces influenza A virus replication by restricting viral RNA synthesis. Antiviral Research. 100: 29-37. PMID 23891991 DOI: 10.1016/J.Antiviral.2013.07.010  0.616
2013 Heaton NS, Leyva-Grado VH, Tan GS, Eggink D, Hai R, Palese P. In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies. Journal of Virology. 87: 8272-81. PMID 23698304 DOI: 10.1128/Jvi.00969-13  0.867
2013 Goff PH, Krammer F, Hai R, Seibert CW, Margine I, García-Sastre A, Palese P. Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin. Journal of Virology. 87: 8235-40. PMID 23698299 DOI: 10.1128/Jvi.01085-13  0.878
2013 Seibert CW, Rahmat S, Krause JC, Eggink D, Albrecht RA, Goff PH, Krammer F, Duty JA, Bouvier NM, García-Sastre A, Palese P. Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs. Journal of Virology. 87: 7793-804. PMID 23698296 DOI: 10.1128/Jvi.00979-13  0.885
2013 Chou YY, Heaton NS, Gao Q, Palese P, Singer RH, Singer R, Lionnet T. Colocalization of different influenza viral RNA segments in the cytoplasm before viral budding as shown by single-molecule sensitivity FISH analysis. Plos Pathogens. 9: e1003358. PMID 23671419 DOI: 10.1371/Journal.Ppat.1003358  0.81
2013 Krammer F, Pica N, Hai R, Margine I, Palese P. Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. Journal of Virology. 87: 6542-50. PMID 23576508 DOI: 10.1128/Jvi.00641-13  0.86
2013 Alamares-Sapuay JG, Martinez-Gil L, Stertz S, Miller MS, Shaw ML, Palese P. Serum- and glucocorticoid-regulated kinase 1 is required for nuclear export of the ribonucleoprotein of influenza A virus. Journal of Virology. 87: 6020-6. PMID 23487453 DOI: 10.1128/Jvi.01258-12  0.635
2013 Margine I, Hai R, Albrecht RA, Obermoser G, Harrod AC, Banchereau J, Palucka K, García-Sastre A, Palese P, Treanor JJ, Krammer F. H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice. Journal of Virology. 87: 4728-37. PMID 23408625 DOI: 10.1128/Jvi.03509-12  0.893
2013 Fouchier RA, García-Sastre A, Kawaoka Y, Barclay WS, Bouvier NM, Brown IH, Capua I, Chen H, Compans RW, Couch RB, Cox NJ, Doherty PC, Donis RO, Feldmann H, Guan Y, ... ... Palese P, et al. Transmission studies resume for avian flu. Science (New York, N.Y.). 339: 520-1. PMID 23345603 DOI: 10.1126/Science.1235140  0.512
2013 Pica N, Palese P. Toward a universal influenza virus vaccine: prospects and challenges. Annual Review of Medicine. 64: 189-202. PMID 23327522 DOI: 10.1146/Annurev-Med-120611-145115  0.841
2013 Martínez-Gil L, Goff PH, Hai R, García-Sastre A, Shaw ML, Palese P. A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant. Journal of Virology. 87: 1290-300. PMID 23175362 DOI: 10.1128/Jvi.02338-12  0.723
2013 Miller MS, Tsibane T, Krammer F, Hai R, Rahmat S, Basler CF, Palese P. 1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans. The Journal of Infectious Diseases. 207: 98-105. PMID 23087428 DOI: 10.1093/Infdis/Jis652  0.705
2013 Zamarin D, Holmgaard R, Subudhi S, Mansour M, Palese P, Merghoub T, Wolchok JD, Allison JP. Localized oncolytic virotherapy inflames distant tumors and synergizes with immune checkpoint blockade leading to systemic tumor rejection Journal For Immunotherapy of Cancer. 1. DOI: 10.1186/2051-1426-1-S1-O9  0.605
2013 Palese P. Influenza and its viruses Schaechter's Mechanisms of Microbial Disease: Fifth Edition. 374-381.  0.592
2012 Martínez-Gil L, Ayllon J, Ortigoza MB, García-Sastre A, Shaw ML, Palese P. Identification of small molecules with type I interferon inducing properties by high-throughput screening. Plos One. 7: e49049. PMID 23145065 DOI: 10.1371/Journal.Pone.0049049  0.813
2012 Ekiert DC, Kashyap AK, Steel J, Rubrum A, Bhabha G, Khayat R, Lee JH, Dillon MA, O'Neil RE, Faynboym AM, Horowitz M, Horowitz L, Ward AB, Palese P, Webby R, et al. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature. 489: 526-32. PMID 22982990 DOI: 10.1038/Nature11414  0.439
2012 Krammer F, Margine I, Tan GS, Pica N, Krause JC, Palese P. A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates. Plos One. 7: e43603. PMID 22928001 DOI: 10.1371/Journal.Pone.0043603  0.826
2012 Goff PH, Gao Q, Palese P. A majority of infectious Newcastle disease virus particles contain a single genome, while a minority contain multiple genomes. Journal of Virology. 86: 10852-6. PMID 22787227 DOI: 10.1128/Jvi.01298-12  0.365
2012 Krammer F, Pica N, Hai R, Tan GS, Palese P. Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice. Journal of Virology. 86: 10302-7. PMID 22787225 DOI: 10.1128/Jvi.01336-12  0.883
2012 Pica N, Langlois RA, Krammer F, Margine I, Palese P. NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge. Journal of Virology. 86: 10293-301. PMID 22787224 DOI: 10.1128/Jvi.01131-12  0.843
2012 Leyva-Grado VH, Mubareka S, Krammer F, Cárdenas WB, Palese P. Influenza virus infection in guinea pigs raised as livestock, Ecuador. Emerging Infectious Diseases. 18: 1135-8. PMID 22710350 DOI: 10.3201/Eid1807.111930  0.681
2012 Varga ZT, Grant A, Manicassamy B, Palese P. Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. Journal of Virology. 86: 8359-66. PMID 22674996 DOI: 10.1128/Jvi.01122-12  0.643
2012 Ortigoza MB, Dibben O, Maamary J, Martinez-Gil L, Leyva-Grado VH, Abreu P, Ayllon J, Palese P, Shaw ML. A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon. Plos Pathogens. 8: e1002668. PMID 22577360 DOI: 10.1371/Journal.Ppat.1002668  0.892
2012 Chou YY, Vafabakhsh R, Doğanay S, Gao Q, Ha T, Palese P. One influenza virus particle packages eight unique viral RNAs as shown by FISH analysis. Proceedings of the National Academy of Sciences of the United States of America. 109: 9101-6. PMID 22547828 DOI: 10.1073/Pnas.1206069109  0.725
2012 Gao Q, Chou YY, Doğanay S, Vafabakhsh R, Ha T, Palese P. The influenza A virus PB2, PA, NP, and M segments play a pivotal role during genome packaging. Journal of Virology. 86: 7043-51. PMID 22532680 DOI: 10.1128/Jvi.00662-12  0.747
2012 Tan GS, Krammer F, Eggink D, Kongchanagul A, Moran TM, Palese P. A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo. Journal of Virology. 86: 6179-88. PMID 22491456 DOI: 10.1128/Jvi.00469-12  0.611
2012 Maamary J, Pica N, Belicha-Villanueva A, Chou YY, Krammer F, Gao Q, García-Sastre A, Palese P. Attenuated influenza virus construct with enhanced hemagglutinin protein expression. Journal of Virology. 86: 5782-90. PMID 22398291 DOI: 10.1128/Jvi.00190-12  0.889
2012 Hai R, Krammer F, Tan GS, Pica N, Eggink D, Maamary J, Margine I, Albrecht RA, Palese P. Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. Journal of Virology. 86: 5774-81. PMID 22398287 DOI: 10.1128/Jvi.00137-12  0.864
2012 Zamarin D, Palese P. Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions. Future Microbiology. 7: 347-67. PMID 22393889 DOI: 10.2217/Fmb.12.4  0.706
2012 Wang TT, Parides MK, Palese P. Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science (New York, N.Y.). 335: 1463. PMID 22362880 DOI: 10.1126/Science.1218888  0.493
2012 Seibert CW, Rahmat S, Krammer F, Palese P, Bouvier NM. Efficient transmission of pandemic H1N1 influenza viruses with high-level oseltamivir resistance. Journal of Virology. 86: 5386-9. PMID 22345446 DOI: 10.1128/Jvi.00151-12  0.846
2012 Pica N, Hai R, Krammer F, Wang TT, Maamary J, Eggink D, Tan GS, Krause JC, Moran T, Stein CR, Banach D, Wrammert J, Belshe RB, García-Sastre A, Palese P. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proceedings of the National Academy of Sciences of the United States of America. 109: 2573-8. PMID 22308500 DOI: 10.1073/Pnas.1200039109  0.888
2012 Palese P, Wang TT. H5N1 influenza viruses: facts, not fear. Proceedings of the National Academy of Sciences of the United States of America. 109: 2211-3. PMID 22308474 DOI: 10.1073/Pnas.1121297109  0.558
2012 Pica N, Chou YY, Bouvier NM, Palese P. Transmission of influenza B viruses in the guinea pig. Journal of Virology. 86: 4279-87. PMID 22301149 DOI: 10.1128/Jvi.06645-11  0.882
2012 Fouchier RA, García-Sastre A, Kawaoka Y, Barclay WS, Bouvier NM, Brown IH, Capua I, Chen H, Compans RW, Couch RB, Cox NJ, Doherty PC, Donis RO, Feldmann H, Guan Y, ... ... Palese P, et al. Pause on avian flu transmission research. Science (New York, N.Y.). 335: 400-1. PMID 22282787 DOI: 10.1126/science.335.6067.400  0.622
2012 Palese P. Don't censor life-saving science. Nature. 481: 115. PMID 22237069 DOI: 10.1038/481115A  0.465
2012 Wang TT, Palese P. Response to comment on "seroevidence for H5N1 influenza infections in humans: Meta-analysis" Science. 336. DOI: 10.1126/Science.1221633  0.549
2012 Palese P. 128 Toward a Universal Influenza Virus Vaccine Jaids Journal of Acquired Immune Deficiency Syndromes. 59: 53. DOI: 10.1097/01.qai.0000413747.69761.5b  0.552
2012 Palese P, Wang TT. Reply to Osterholm and Kelley: H5N1 in humans-the threat is not as bad as it may seem Proceedings of the National Academy of Sciences of the United States of America. 109. DOI: 10.1073/Pnas.1204160109  0.581
2011 Varga ZT, Palese P. The influenza A virus protein PB1-F2: killing two birds with one stone? Virulence. 2: 542-6. PMID 21971186 DOI: 10.4161/Viru.2.6.17812  0.673
2011 Li P, Chen CH, Li S, Givi B, Yu Z, Zamarin D, Palese P, Fong Y, Wong RJ. Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer. Head & Neck. 33: 1394-9. PMID 21928411 DOI: 10.1002/Hed.21609  0.644
2011 Pica N, Iyer A, Ramos I, Bouvier NM, Fernandez-Sesma A, García-Sastre A, Lowen AC, Palese P, Steel J. The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses. Journal of Virology. 85: 12825-9. PMID 21917963 DOI: 10.1128/Jvi.05930-11  0.866
2011 Chou YY, Albrecht RA, Pica N, Lowen AC, Richt JA, García-Sastre A, Palese P, Hai R. The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model. Journal of Virology. 85: 11235-41. PMID 21880744 DOI: 10.1128/Jvi.05794-11  0.891
2011 Palese P, Wang TT. Why do influenza virus subtypes die out? A hypothesis. Mbio. 2. PMID 21878571 DOI: 10.1128/Mbio.00150-11  0.673
2011 Wang TT, Palese P. Biochemistry. Catching a moving target. Science (New York, N.Y.). 333: 834-5. PMID 21836007 DOI: 10.1126/Science.1210724  0.571
2011 Varga ZT, Ramos I, Hai R, Schmolke M, García-Sastre A, Fernandez-Sesma A, Palese P. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. Plos Pathogens. 7: e1002067. PMID 21695240 DOI: 10.1371/Journal.Ppat.1002067  0.755
2011 Hai R, García-Sastre A, Swayne DE, Palese P. A reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains. Journal of Virology. 85: 6832-43. PMID 21543486 DOI: 10.1128/Jvi.00609-11  0.809
2011 Mansour M, Palese P, Zamarin D. Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells. Journal of Virology. 85: 6015-23. PMID 21471241 DOI: 10.1128/Jvi.01537-10  0.645
2011 Hoffmann HH, Kunz A, Simon VA, Palese P, Shaw ML. Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis. Proceedings of the National Academy of Sciences of the United States of America. 108: 5777-82. PMID 21436031 DOI: 10.1073/Pnas.1101143108  0.616
2011 Yondola MA, Fernandes F, Belicha-Villanueva A, Uccelini M, Gao Q, Carter C, Palese P. Budding capability of the influenza virus neuraminidase can be modulated by tetherin. Journal of Virology. 85: 2480-91. PMID 21209114 DOI: 10.1128/Jvi.02188-10  0.639
2011 Maamary J, Array F, Gao Q, García-Sastre A, Steinman RM, Palese P, Nchinda G. Newcastle disease virus expressing a dendritic cell-targeted HIV gag protein induces a potent gag-specific immune response in mice. Journal of Virology. 85: 2235-46. PMID 21159873 DOI: 10.1128/Jvi.02036-10  0.796
2011 Steel J, Palese P, Lowen AC. Transmission of a 2009 pandemic influenza virus shows a sensitivity to temperature and humidity similar to that of an H3N2 seasonal strain. Journal of Virology. 85: 1400-2. PMID 21084485 DOI: 10.1128/Jvi.02186-10  0.641
2011 Conenello GM, Tisoncik JR, Rosenzweig E, Varga ZT, Palese P, Katze MG. A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo. Journal of Virology. 85: 652-62. PMID 21084483 DOI: 10.1128/Jvi.01987-10  0.857
2011 Mubareka S, Palese P. Influenza virus: The biology of a changing virus Birkhauser Advances in Infectious Diseases. 3-26. DOI: 10.1007/978-3-0346-0279-2_1  0.604
2011 Pica N, Palese P, Steel J. Live attenuated influenza virus vaccines: Ns1 truncation as an approach to virus attenuation Birkhauser Advances in Infectious Diseases. 195-221. DOI: 10.1007/978-3-0346-0277-8_8  0.858
2010 Medina RA, Manicassamy B, Stertz S, Seibert CW, Hai R, Belshe RB, Frey SE, Basler CF, Palese P, García-Sastre A. Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus. Nature Communications. 1: 28. PMID 20975689 DOI: 10.1038/Ncomms1026  0.896
2010 Wang TT, Tan GS, Hai R, Pica N, Ngai L, Ekiert DC, Wilson IA, García-Sastre A, Moran TM, Palese P. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proceedings of the National Academy of Sciences of the United States of America. 107: 18979-84. PMID 20956293 DOI: 10.1073/Pnas.1013387107  0.888
2010 Seibert CW, Kaminski M, Philipp J, Rubbenstroth D, Albrecht RA, Schwalm F, Stertz S, Medina RA, Kochs G, García-Sastre A, Staeheli P, Palese P. Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. Journal of Virology. 84: 11219-26. PMID 20739532 DOI: 10.1128/Jvi.01424-10  0.877
2010 Steel J, Lowen AC, Wang TT, Yondola M, Gao Q, Haye K, García-Sastre A, Palese P. Influenza virus vaccine based on the conserved hemagglutinin stalk domain. Mbio. 1. PMID 20689752 DOI: 10.1128/Mbio.00018-10  0.603
2010 Kashyap AK, Steel J, Rubrum A, Estelles A, Briante R, Ilyushina NA, Xu L, Swale RE, Faynboym AM, Foreman PK, Horowitz M, Horowitz L, Webby R, Palese P, Lerner RA, et al. Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries. Plos Pathogens. 6: e1000990. PMID 20628565 DOI: 10.1371/Journal.Ppat.1000990  0.686
2010 Gao Q, Lowen AC, Wang TT, Palese P. A nine-segment influenza a virus carrying subtype H1 and H3 hemagglutinins. Journal of Virology. 84: 8062-71. PMID 20519387 DOI: 10.1128/Jvi.00722-10  0.608
2010 Wang TT, Tan GS, Hai R, Pica N, Petersen E, Moran TM, Palese P. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. Plos Pathogens. 6: e1000796. PMID 20195520 DOI: 10.1371/Journal.Ppat.1000796  0.878
2010 Hai R, Schmolke M, Varga ZT, Manicassamy B, Wang TT, Belser JA, Pearce MB, García-Sastre A, Tumpey TM, Palese P. PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. Journal of Virology. 84: 4442-50. PMID 20181699 DOI: 10.1128/Jvi.02717-09  0.815
2010 Manicassamy B, Medina RA, Hai R, Tsibane T, Stertz S, Nistal-Villán E, Palese P, Basler CF, García-Sastre A. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. Plos Pathogens. 6: e1000745. PMID 20126449 DOI: 10.1371/Journal.Ppat.1000745  0.807
2010 König R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, Alamares JG, Tscherne DM, Ortigoza MB, Liang Y, Gao Q, Andrews SE, Bandyopadhyay S, De Jesus P, Tu BP, ... ... Palese P, et al. Human host factors required for influenza virus replication. Nature. 463: 813-7. PMID 20027183 DOI: 10.1038/Nature08699  0.87
2010 Martínez-Sobrido L, Cadagan R, Steel J, Basler CF, Palese P, Moran TM, García-Sastre A. Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies. Journal of Virology. 84: 2157-63. PMID 19939917 DOI: 10.1128/Jvi.01433-09  0.68
2010 Wong J, Schulman A, Kelly K, Zamarin D, Palese P, Fong Y. Detection of free peritoneal cancer cells in gastric cancer using cancer-specific Newcastle disease virus. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 14: 7-14. PMID 19902312 DOI: 10.1007/S11605-009-1071-8  0.578
2010 Steel J, Staeheli P, Mubareka S, García-Sastre A, Palese P, Lowen AC. Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. Journal of Virology. 84: 21-6. PMID 19828604 DOI: 10.1128/Jvi.01732-09  0.655
2009 Lowen A, Palese P. Transmission of influenza virus in temperate zones is predominantly by aerosol, in the tropics by contact: a hypothesis. Plos Currents. 1: RRN1002. PMID 20025197 DOI: 10.1371/Currents.Rrn1002  0.611
2009 Gao Q, Palese P. Rewiring the RNAs of influenza virus to prevent reassortment. Proceedings of the National Academy of Sciences of the United States of America. 106: 15891-6. PMID 19805230 DOI: 10.1073/Pnas.0908897106  0.612
2009 Kopecky-Bromberg SA, Palese P. Recombinant vectors as influenza vaccines. Current Topics in Microbiology and Immunology. 333: 243-67. PMID 19768410 DOI: 10.1007/978-3-540-92165-3_13  0.65
2009 Wang TT, Palese P. Unraveling the mystery of swine influenza virus. Cell. 137: 983-5. PMID 19524497 DOI: 10.1016/J.Cell.2009.05.032  0.688
2009 Kopecky-Bromberg SA, Fraser KA, Pica N, Carnero E, Moran TM, Franck RW, Tsuji M, Palese P. Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine. 27: 3766-74. PMID 19464560 DOI: 10.1016/J.Vaccine.2009.03.090  0.837
2009 Mubareka S, Lowen AC, Steel J, Coates AL, García-Sastre A, Palese P. Transmission of influenza virus via aerosols and fomites in the guinea pig model. The Journal of Infectious Diseases. 199: 858-65. PMID 19434931 DOI: 10.1086/597073  0.651
2009 Chambers TM, Quinlivan M, Sturgill T, Cullinane A, Horohov DW, Zamarin D, Arkins S, García-Sastre A, Palese P. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses. Equine Veterinary Journal. 41: 87-92. PMID 19301588 DOI: 10.2746/042516408X371937  0.805
2009 Wang TT, Palese P. Universal epitopes of influenza virus hemagglutinins? Nature Structural & Molecular Biology. 16: 233-4. PMID 19234464 DOI: 10.1038/Nsmb.1574  0.689
2009 Kulkarni S, Volchkova V, Basler CF, Palese P, Volchkov VE, Shaw ML. Nipah virus edits its P gene at high frequency to express the V and W proteins. Journal of Virology. 83: 3982-7. PMID 19211754 DOI: 10.1128/Jvi.02599-08  0.372
2009 Zamarin D, Martínez-Sobrido L, Kelly K, Mansour M, Sheng G, Vigil A, García-Sastre A, Palese P, Fong Y. Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 697-706. PMID 19209145 DOI: 10.1038/Mt.2008.286  0.725
2009 Lowen AC, Steel J, Mubareka S, Carnero E, García-Sastre A, Palese P. Blocking interhost transmission of influenza virus by vaccination in the guinea pig model. Journal of Virology. 83: 2803-18. PMID 19153237 DOI: 10.1128/Jvi.02424-08  0.652
2009 Abbadessa G, Accolla R, Aiuti F, Albini A, Aldovini A, Alfano M, Antonelli G, Bartholomew C, Bentwich Z, Bertazzoni U, Berzofsky JA, Biberfeld P, Boeri E, Buonaguro L, Buonaguro FM, ... ... Palese P, et al. Unsung hero Robert C. Gallo. Science (New York, N.Y.). 323: 206-7. PMID 19131607 DOI: 10.1126/Science.323.5911.206  0.369
2009 Steel J, Lowen AC, Mubareka S, Palese P. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. Plos Pathogens. 5: e1000252. PMID 19119420 DOI: 10.1371/Journal.Ppat.1000252  0.619
2009 Steel J, Lowen AC, Pena L, Angel M, Solórzano A, Albrecht R, Perez DR, García-Sastre A, Palese P. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. Journal of Virology. 83: 1742-53. PMID 19073731 DOI: 10.1128/Jvi.01920-08  0.693
2009 Wong J, Schulman A, Kelly K, Zamarin D, Palese P, Fong Y. 1015 Enhancing Detection of Free Peritoneal Cancer Cells in Gastric Cancer Using Newcastle Disease Virus Gastroenterology. 136: A-883. DOI: 10.1016/S0016-5085(09)64078-6  0.596
2008 Bouvier NM, Palese P. The biology of influenza viruses. Vaccine. 26: D49-53. PMID 19230160 DOI: 10.1016/J.Vaccine.2008.07.039  0.607
2008 Hai R, Martínez-Sobrido L, Fraser KA, Ayllon J, García-Sastre A, Palese P. Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach. Journal of Virology. 82: 10580-90. PMID 18768976 DOI: 10.1128/Jvi.01213-08  0.771
2008 Bouvier NM, Lowen AC, Palese P. Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol. Journal of Virology. 82: 10052-8. PMID 18684820 DOI: 10.1128/Jvi.01226-08  0.576
2008 Hoffmann HH, Palese P, Shaw ML. Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity. Antiviral Research. 80: 124-34. PMID 18585796 DOI: 10.1016/J.Antiviral.2008.05.008  0.615
2008 Shaw ML, Stone KL, Colangelo CM, Gulcicek EE, Palese P. Cellular proteins in influenza virus particles. Plos Pathogens. 4: e1000085. PMID 18535660 DOI: 10.1371/Journal.Ppat.1000085  0.669
2008 Gao Q, Brydon EW, Palese P. A seven-segmented influenza A virus expressing the influenza C virus glycoprotein HEF. Journal of Virology. 82: 6419-26. PMID 18448539 DOI: 10.1128/Jvi.00514-08  0.635
2008 Kashyap AK, Steel J, Oner AF, Dillon MA, Swale RE, Wall KM, Perry KJ, Faynboym A, Ilhan M, Horowitz M, Horowitz L, Palese P, Bhatt RR, Lerner RA. Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proceedings of the National Academy of Sciences of the United States of America. 105: 5986-91. PMID 18413603 DOI: 10.1073/Pnas.0801367105  0.664
2008 Lowen AC, Steel J, Mubareka S, Palese P. High temperature (30 degrees C) blocks aerosol but not contact transmission of influenza virus. Journal of Virology. 82: 5650-2. PMID 18367530 DOI: 10.1128/Jvi.00325-08  0.558
2008 Pappas C, Aguilar PV, Basler CF, Solórzano A, Zeng H, Perrone LA, Palese P, García-Sastre A, Katz JM, Tumpey TM. Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proceedings of the National Academy of Sciences of the United States of America. 105: 3064-9. PMID 18287069 DOI: 10.1073/Pnas.0711815105  0.67
2008 Gao Q, Park MS, Palese P. Expression of transgenes from newcastle disease virus with a segmented genome. Journal of Virology. 82: 2692-8. PMID 18199643 DOI: 10.1128/Jvi.02341-07  0.484
2008 Mubareka S, Palese P. Human genes and influenza. The Journal of Infectious Diseases. 197: 1-3. PMID 18171276 DOI: 10.1086/524067  0.515
2008 Marsh GA, Rabadán R, Levine AJ, Palese P. Highly conserved regions of influenza a virus polymerase gene segments are critical for efficient viral RNA packaging. Journal of Virology. 82: 2295-304. PMID 18094182 DOI: 10.1128/Jvi.02267-07  0.55
2008 Steel J, Burmakina SV, Thomas C, Spackman E, García-Sastre A, Swayne DE, Palese P. A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus. Vaccine. 26: 522-31. PMID 18093698 DOI: 10.1016/J.Vaccine.2007.11.032  0.7
2008 Steel J, Palese P. The 1918 influenza pandemic: Lessons from the past raise questions for the future Monographs in Virology. 27: 272-286. DOI: 10.1159/000151660  0.566
2007 Legastelois I, Garcia-Sastre A, Palese P, Tumpey TM, Maines TR, Katz JM, Vogel FR, Moste C. Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells. Influenza and Other Respiratory Viruses. 1: 95-104. PMID 19453414 DOI: 10.1111/J.1750-2659.2007.00015.X  0.627
2007 Lowen AC, Palese P. Influenza virus transmission: basic science and implications for the use of antiviral drugs during a pandemic. Infectious Disorders Drug Targets. 7: 318-28. PMID 18220963 DOI: 10.2174/187152607783018736  0.627
2007 Conenello GM, Palese P. Influenza A virus PB1-F2: a small protein with a big punch. Cell Host & Microbe. 2: 207-9. PMID 18005736 DOI: 10.1016/J.Chom.2007.09.010  0.874
2007 Lowen AC, Mubareka S, Steel J, Palese P. Influenza virus transmission is dependent on relative humidity and temperature. Plos Pathogens. 3: 1470-6. PMID 17953482 DOI: 10.1371/Journal.Ppat.0030151  0.522
2007 Ahmed R, Oldstone MB, Palese P. Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nature Immunology. 8: 1188-93. PMID 17952044 DOI: 10.1038/Ni1530  0.489
2007 Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. Plos Pathogens. 3: 1414-21. PMID 17922571 DOI: 10.1371/Journal.Ppat.0030141  0.875
2007 Marsh GA, Hatami R, Palese P. Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions. Journal of Virology. 81: 9727-36. PMID 17634232 DOI: 10.1128/Jvi.01144-07  0.669
2007 Frieman M, Yount B, Heise M, Kopecky-Bromberg SA, Palese P, Baric RS. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. Journal of Virology. 81: 9812-24. PMID 17596301 DOI: 10.1128/Jvi.01012-07  0.328
2007 He Q, Martinez-Sobrido L, Eko FO, Palese P, Garcia-Sastre A, Lyn D, Okenu D, Bandea C, Ananaba GA, Black CM, Igietseme JU. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines. Immunology. 122: 28-37. PMID 17451464 DOI: 10.1111/J.1365-2567.2007.02608.X  0.543
2007 Glaser L, Conenello G, Paulson J, Palese P. Effective replication of human influenza viruses in mice lacking a major alpha2,6 sialyltransferase. Virus Research. 126: 9-18. PMID 17313986 DOI: 10.1016/J.Virusres.2007.01.011  0.85
2007 Tumpey TM, Maines TR, Van Hoeven N, Glaser L, Solórzano A, Pappas C, Cox NJ, Swayne DE, Palese P, Katz JM, García-Sastre A. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science (New York, N.Y.). 315: 655-9. PMID 17272724 DOI: 10.1126/Science.1136212  0.74
2007 Kopecky-Bromberg SA, Martínez-Sobrido L, Frieman M, Baric RA, Palese P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. Journal of Virology. 81: 548-57. PMID 17108024 DOI: 10.1128/Jvi.01782-06  0.356
2006 Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, Thomas MJ, Basler CF, Palese P, Taubenberger JK, García-Sastre A, Swayne DE, Katze MG. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature. 443: 578-81. PMID 17006449 DOI: 10.1038/Nature05181  0.654
2006 Zamarin D, Ortigoza MB, Palese P. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. Journal of Virology. 80: 7976-83. PMID 16873254 DOI: 10.1128/Jvi.00415-06  0.882
2006 Lowen AC, Mubareka S, Tumpey TM, García-Sastre A, Palese P. The guinea pig as a transmission model for human influenza viruses. Proceedings of the National Academy of Sciences of the United States of America. 103: 9988-92. PMID 16785447 DOI: 10.1073/Pnas.0604157103  0.682
2006 Park MS, Steel J, García-Sastre A, Swayne D, Palese P. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proceedings of the National Academy of Sciences of the United States of America. 103: 8203-8. PMID 16717196 DOI: 10.1073/Pnas.0602566103  0.692
2006 Glaser L, Zamarin D, Acland HM, Spackman E, Palese P, García-Sastre A, Tewari D. Sequence analysis and receptor specificity of the hemagglutinin of a recent influenza H2N2 virus isolated from chicken in North America. Glycoconjugate Journal. 23: 93-9. PMID 16575526 DOI: 10.1007/S10719-006-5441-0  0.836
2006 Palese P. Making better influenza virus vaccines? Emerging Infectious Diseases. 12: 61-5. PMID 16494719 DOI: 10.3201/Eid1201.051043  0.577
2006 Palese P, Tumpey TM, Garcia-Sastre A. What can we learn from reconstructing the extinct 1918 pandemic influenza virus? Immunity. 24: 121-4. PMID 16473822 DOI: 10.1016/J.Immuni.2006.01.007  0.518
2006 Stevens J, Blixt O, Glaser L, Taubenberger JK, Palese P, Paulson JC, Wilson IA. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. Journal of Molecular Biology. 355: 1143-55. PMID 16343533 DOI: 10.1016/J.Jmb.2005.11.002  0.697
2006 Palese P. Influenza pandemics: past and future Retrovirology. 3. DOI: 10.1186/1742-4690-3-S1-S55  0.711
2005 Tumpey TM, García-Sastre A, Taubenberger JK, Palese P, Swayne DE, Pantin-Jackwood MJ, Schultz-Cherry S, Solórzano A, Van Rooijen N, Katz JM, Basler CF. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. Journal of Virology. 79: 14933-44. PMID 16282492 DOI: 10.1128/Jvi.79.23.14933-14944.2005  0.658
2005 Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solórzano A, Swayne DE, Cox NJ, Katz JM, Taubenberger JK, Palese P, García-Sastre A. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science (New York, N.Y.). 310: 77-80. PMID 16210530 DOI: 10.1126/Science.1119392  0.696
2005 Zamarin D, García-Sastre A, Xiao X, Wang R, Palese P. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. Plos Pathogens. 1: e4. PMID 16201016 DOI: 10.1371/Journal.Ppat.0010004  0.603
2005 Glaser L, Stevens J, Zamarin D, Wilson IA, García-Sastre A, Tumpey TM, Basler CF, Taubenberger JK, Palese P. A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. Journal of Virology. 79: 11533-6. PMID 16103207 DOI: 10.1128/Jvi.79.17.11533-11536.2005  0.762
2005 Quinlivan M, Zamarin D, García-Sastre A, Cullinane A, Chambers T, Palese P. Attenuation of equine influenza viruses through truncations of the NS1 protein. Journal of Virology. 79: 8431-9. PMID 15956587 DOI: 10.1128/Jvi.79.13.8431-8439.2005  0.815
2005 Efferson CL, Kawano K, Tsuda N, Palese P, García-Sastre A, Ioannides CG. Stimulation of human T cells by an influenza A vector expressing a CTL epitope from the HER-2/neu protooncogene results in higher numbers of antigen-specific TCRhi cells than stimulation with peptide. Divergent roles of IL-2 and IL-15. Anticancer Research. 25: 715-24. PMID 15868901  0.313
2005 Shaw ML, Cardenas WB, Zamarin D, Palese P, Basler CF. Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. Journal of Virology. 79: 6078-88. PMID 15857993 DOI: 10.1128/Jvi.79.10.6078-6088.2005  0.654
2005 Cros JF, García-Sastre A, Palese P. An unconventional NLS is critical for the nuclear import of the influenza A virus nucleoprotein and ribonucleoprotein. Traffic (Copenhagen, Denmark). 6: 205-13. PMID 15702989 DOI: 10.1111/J.1600-0854.2005.00263.X  0.641
2005 Chang DZ, Tsuda N, Ohtani S, Palese P, Garcia-Sastre A, Ioannides CG, Abbruzzese JL. HER-2-Nascent Polypeptide Chain Bound on Ribosomes Translating Influenza Virus Proteins Induces Differentiation of CD8+ Cells Journal of Immunotherapy. 28: 654-655. DOI: 10.1097/01.Cji.0000191085.66781.Ab  0.537
2005 Shaw ML, Palese P. Viruses and the innate immune system: Answers and yet more questions Modulation of Host Gene Expression and Innate Immunity by Viruses. 1-18. DOI: 10.1007/1-4020-3242-0_1  0.387
2005 Palese P. Modulation of host gene expression and innate immunity by viruses Modulation of Host Gene Expression and Innate Immunity by Viruses. 1-304. DOI: 10.1007/1-4020-3242-0  0.388
2004 Palese P. Influenza: old and new threats. Nature Medicine. 10: S82-7. PMID 15577936 DOI: 10.1038/Nm1141  0.665
2004 Nakaya Y, Nakaya T, Park MS, Cros J, Imanishi J, Palese P, García-Sastre A. Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors. Journal of Virology. 78: 9366-75. PMID 15308731 DOI: 10.1128/Jvi.78.17.9366-9375.2004  0.737
2004 Shaw ML, García-Sastre A, Palese P, Basler CF. Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. Journal of Virology. 78: 5633-41. PMID 15140960 DOI: 10.1128/Jvi.78.11.5633-5641.2004  0.42
2004 Tumpey TM, García-Sastre A, Taubenberger JK, Palese P, Swayne DE, Basler CF. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proceedings of the National Academy of Sciences of the United States of America. 101: 3166-71. PMID 14963236 DOI: 10.1073/Pnas.0308391100  0.711
2004 Stevens J, Corper AL, Basler CF, Taubenberger JK, Palese P, Wilson IA. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science (New York, N.Y.). 303: 1866-70. PMID 14764887 DOI: 10.1126/Science.1093373  0.605
2004 Li WX, Li H, Lu R, Li F, Dus M, Atkinson P, Brydon EW, Johnson KL, García-Sastre A, Ball LA, Palese P, Ding SW. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proceedings of the National Academy of Sciences of the United States of America. 101: 1350-5. PMID 14745017 DOI: 10.1073/Pnas.0308308100  0.543
2004 Palese P. New Challenges to Health: The Threat of Virus Infection (review) Human Biology. 76: 320-321. DOI: 10.1353/hub.2004.0036  0.338
2004 Palese P. The great influenza The epic story of the deadliest plague in history Journal of Clinical Investigation. 114: 146-146. DOI: 10.1172/Jci22439  0.475
2004 Efferson C, Kawano K, Sellappan S, Yu D, Babaian R, Palese P, Garcia-Sastre A, Ioannides C, Murray J. Prostate Tumor Cells Infected with a Recombinant Influenza Virus with Truncated NS1 Gene NS1 (1-126) Activate Cytolytic CD8+ Cells Which Recognize Non-Infected Tumors Journal of Immunotherapy. 27: S53. DOI: 10.1097/00002371-200411000-00190  0.447
2003 Swayne DE, Suarez DL, Schultz-Cherry S, Tumpey TM, King DJ, Nakaya T, Palese P, Garcia-Sastre A. Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease. Avian Diseases. 47: 1047-50. PMID 14575108 DOI: 10.1637/0005-2086-47.S3.1047  0.545
2003 González-Aseguinolaza G, Nakaya Y, Molano A, Dy E, Esteban M, Rodríguez D, Rodríguez JR, Palese P, García-Sastre A, Nussenzweig RS. Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived from the circumsporozoite protein of Plasmodium yoelii. Journal of Virology. 77: 11859-66. PMID 14557672 DOI: 10.1128/Jvi.77.21.11859-11866.2003  0.624
2003 Cros JF, Palese P. Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses. Virus Research. 95: 3-12. PMID 12921991 DOI: 10.1016/S0168-1702(03)00159-X  0.67
2003 Park MS, García-Sastre A, Cros JF, Basler CF, Palese P. Newcastle disease virus V protein is a determinant of host range restriction. Journal of Virology. 77: 9522-32. PMID 12915566 DOI: 10.1128/Jvi.77.17.9522-9532.2003  0.663
2003 Flandorfer A, García-Sastre A, Basler CF, Palese P. Chimeric influenza A viruses with a functional influenza B virus neuraminidase or hemagglutinin. Journal of Virology. 77: 9116-23. PMID 12915528 DOI: 10.1128/Jvi.77.17.9116-9123.2003  0.676
2003 Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Mühlberger E, Bray M, Klenk HD, Palese P, García-Sastre A. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. Journal of Virology. 77: 7945-56. PMID 12829834 DOI: 10.1128/Jvi.77.14.7945-7956.2003  0.801
2003 Efferson CL, Schickli J, Ko BK, Kawano K, Mouzi S, Palese P, García-Sastre A, Ioannides CG. Activation of tumor antigen-specific cytotoxic T lymphocytes (CTLs) by human dendritic cells infected with an attenuated influenza A virus expressing a CTL epitope derived from the HER-2/neu proto-oncogene. Journal of Virology. 77: 7411-24. PMID 12805440 DOI: 10.1128/Jvi.77.13.7411-7424.2003  0.546
2003 Park MS, Shaw ML, Muñoz-Jordan J, Cros JF, Nakaya T, Bouvier N, Palese P, García-Sastre A, Basler CF. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. Journal of Virology. 77: 1501-11. PMID 12502864 DOI: 10.1128/Jvi.77.2.1501-1511.2003  0.72
2002 Wang X, Basler CF, Williams BR, Silverman RH, Palese P, García-Sastre A. Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domains. Journal of Virology. 76: 12951-62. PMID 12438621 DOI: 10.1128/Jvi.76.24.12951-12962.2002  0.569
2002 Tumpey TM, García-Sastre A, Mikulasova A, Taubenberger JK, Swayne DE, Palese P, Basler CF. Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proceedings of the National Academy of Sciences of the United States of America. 99: 13849-54. PMID 12368467 DOI: 10.1073/Pnas.212519699  0.651
2002 Geiss GK, Salvatore M, Tumpey TM, Carter VS, Wang X, Basler CF, Taubenberger JK, Bumgarner RE, Palese P, Katze MG, García-Sastre A. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proceedings of the National Academy of Sciences of the United States of America. 99: 10736-41. PMID 12149435 DOI: 10.1073/Pnas.112338099  0.64
2002 Palese P, García-Sastre A. Influenza vaccines: Present and future Journal of Clinical Investigation. 110: 9-13. PMID 12093881 DOI: 10.1172/Jci15999  0.543
2002 Palese P, García-Sastre A. New directions in vaccine research Journal of Clinical Investigation. 109: 1517-1518. PMID 12070295 DOI: 10.1172/Jci15876  0.375
2002 Mora R, Rodriguez-Boulan E, Palese P, García-Sastre A. Apical budding of a recombinant influenza A virus expressing a hemagglutinin protein with a basolateral localization signal. Journal of Virology. 76: 3544-53. PMID 11884578 DOI: 10.1128/Jvi.76.7.3544-3553.2002  0.583
2002 Salvatore M, Basler CF, Parisien JP, Horvath CM, Bourmakina S, Zheng H, Muster T, Palese P, García-Sastre A. Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. Journal of Virology. 76: 1206-12. PMID 11773396 DOI: 10.1128/Jvi.76.3.1206-1212.2002  0.557
2002 Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O'Neill R, Schickli J, Palese P, Henklein P, Bennink JR, Yewdell JW. A novel influenza A virus mitochondrial protein that induces cell death. Nature Medicine. 7: 1306-12. PMID 11726970 DOI: 10.1038/Nm1201-1306  0.59
2001 Schickli JH, Flandorfer A, Nakaya T, Martinez-Sobrido L, García-Sastre A, Palese P. Plasmid-only rescue of influenza A virus vaccine candidates Philosophical Transactions of the Royal Society B: Biological Sciences. 356: 1965-1973. PMID 11779399 DOI: 10.1098/Rstb.2001.0979  0.637
2001 Nakaya T, Cros J, Park MS, Nakaya Y, Zheng H, Sagrera A, Villar E, García-Sastre A, Palese P. Recombinant Newcastle disease virus as a vaccine vector. Journal of Virology. 75: 11868-73. PMID 11689668 DOI: 10.1128/Jvi.75.23.11868-11873.2001  0.799
2001 Paragas J, Talon J, O'Neill RE, Anderson DK, García-Sastre A, Palese P. Influenza B and C virus NEP (NS2) proteins possess nuclear export activities. Journal of Virology. 75: 7375-83. PMID 11462009 DOI: 10.1128/Jvi.75.16.7375-7383.2001  0.874
2001 Basler CF, Reid AH, Dybing JK, Janczewski TA, Fanning TG, Zheng H, Salvatore M, Perdue ML, Swayne DE, García-Sastre A, Palese P, Taubenberger JK. Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proceedings of the National Academy of Sciences of the United States of America. 98: 2746-51. PMID 11226311 DOI: 10.1073/Pnas.031575198  0.666
2001 Momose F, Basler CF, O'Neill RE, Iwamatsu A, Palese P, Nagata K. Cellular splicing factor RAF-2p48/NPI-5/BAT1/UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis. Journal of Virology. 75: 1899-908. PMID 11160689 DOI: 10.1128/Jvi.75.4.1899-1908.2001  0.442
2000 Zheng H, Palese P, García-Sastre A. Antitumor properties of influenza virus vectors Cancer Research. 60: 6972-6976. PMID 11156398  0.455
2000 Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, García-Sastre A. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. Journal of Virology. 74: 11566-73. PMID 11090154 DOI: 10.1128/Jvi.74.24.11566-11573.2000  0.559
2000 Basler CF, Wang X, Mühlberger E, Volchkov V, Paragas J, Klenk HD, García-Sastre A, Palese P. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proceedings of the National Academy of Sciences of the United States of America. 97: 12289-94. PMID 11027311 DOI: 10.1073/Pnas.220398297  0.846
2000 Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, García-Sastre A. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. Journal of Virology. 74: 7989-96. PMID 10933707 DOI: 10.1128/Jvi.74.17.7989-7996.2000  0.872
2000 Bergmann M, Garcia-Sastre A, Carnero E, Pehamberger H, Wolff K, Palese P, Muster T. Influenza Virus NS1 Protein Counteracts PKR-Mediated Inhibition of Replication Journal of Virology. 74: 6203-6206. PMID 10846107 DOI: 10.1128/Jvi.74.13.6203-6206.2000  0.695
2000 Gilleland HE, Gilleland LB, Staczek J, Harty RN, García-Sastre A, Palese P, Brennan FR, Hamilton WD, Bendahmane M, Beachy RN. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection. Fems Immunology and Medical Microbiology. 27: 291-7. PMID 10727884 DOI: 10.1111/J.1574-695X.2000.Tb01442.X  0.592
2000 Talon J, Salvatore M, O'Neill RE, Nakaya Y, Zheng H, Muster T, García-Sastre A, Palese P. Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proceedings of the National Academy of Sciences of the United States of America. 97: 4309-14. PMID 10725408 DOI: 10.1073/Pnas.070525997  0.894
2000 Solorzano A, Zheng H, Fodor E, Brownlee GG, Palese P, García-Sastre A. Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice. The Journal of General Virology. 81: 737-42. PMID 10675411 DOI: 10.1099/0022-1317-81-3-737  0.657
1999 Basler CF, García-Sastre A, Palese P. Mutation of neuraminidase cysteine residues yields temperature-sensitive influenza viruses Journal of Virology. 73: 8095-8103. PMID 10482558 DOI: 10.1128/Jvi.73.10.8095-8103.1999  0.641
1999 Palese P, Muster T, Zheng H, O'Neill R, Garcia-Sastre A. Learning from our foes: a novel vaccine concept for influenza virus. Archives of Virology. Supplementum. 15: 131-8. PMID 10470274 DOI: 10.1007/978-3-7091-6425-9_9  0.7
1999 Zheng H, Lee HA, Palese P, García-Sastre A. Influenza A virus RNA polymerase has the ability to stutter at the polyadenylation site of a viral RNA template during RNA replication Journal of Virology. 73: 5240-5243. PMID 10233995 DOI: 10.1128/Jvi.73.6.5240-5243.1999  0.512
1999 Craven RC, Harty RN, Paragas J, Palese P, Wills JW. Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras Journal of Virology. 73: 3359-3365. PMID 10074190 DOI: 10.1128/Jvi.73.4.3359-3365.1999  0.756
1999 Harty RN, Paragas J, Sudol M, Palese P. A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: Implications for viral budding Journal of Virology. 73: 2921-2929. PMID 10074141 DOI: 10.1128/Jvi.73.4.2921-2929.1999  0.732
1999 Gonzalo RM, Rodríguez D, García-Sastre A, Rodríguez JR, Palese P, Esteban M. Enhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants. Vaccine. 17: 887-92. PMID 10067695 DOI: 10.1016/S0264-410X(98)00274-6  0.453
1999 Craven RC, Harty RN, Paragas J, Palese P, Wills JW. Late Domain Function Identified in the Vesicular Stomatitis Virus M Protein by Use of Rhabdovirus-Retrovirus Chimeras Journal of Virology. 73: 3359-3365. DOI: 10.1128/jvi.73.4.3359-3365.1999  0.737
1998 García-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T. Influenza A virus lacking the NS1 gene replicates in interferon- deficient systems Virology. 252: 324-330. PMID 9878611 DOI: 10.1006/Viro.1998.9508  0.67
1998 Palese P. RNA virus vectors: Where are we and where do we need to go? Proceedings of the National Academy of Sciences of the United States of America. 95: 12750-12752. PMID 9788984 DOI: 10.1073/Pnas.95.22.12750  0.41
1998 Restifo NP, Surman DR, Zheng H, Palese P, Rosenberg SA, García-Sastre A. Transfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancer Virology. 249: 89-97. PMID 9740780 DOI: 10.1006/Viro.1998.9330  0.602
1998 Wolff T, O'Neill RE, Palese P. NS1-binding protein (NS1-BP): A novel human protein that interacts with the influenza A virus nonstructural NS1 protein is relocalized in the nuclei of infected cells Journal of Virology. 72: 7170-7180. PMID 9696811 DOI: 10.1128/Jvi.72.9.7170-7180.1998  0.489
1998 Staczek J, Gilleland J, Gilleland LB, Harty RN, Garcia-Sastre A, Engelhardt OG, Palese P. A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection Infection and Immunity. 66: 3990-3994. PMID 9673294 DOI: 10.1128/Iai.66.8.3990-3994.1998  0.605
1998 Fodor E, Palese P, Brownlee GG, García-Sastre A. Attenuation of influenza A virus mRNA levels by promoter mutations. Journal of Virology. 72: 6283-90. PMID 9658066 DOI: 10.1128/Jvi.72.8.6283-6290.1998  0.558
1998 Miyahira Y, García-Sastre A, Rodriguez D, Rodriguez JR, Murata K, Tsuji M, Palese P, Esteban M, Zavala F, Nussenzweig RS. Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice. Proceedings of the National Academy of Sciences of the United States of America. 95: 3954-9. PMID 9520474 DOI: 10.1073/Pnas.95.7.3954  0.461
1998 O'Neill RE, Talon J, Palese P. The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins Embo Journal. 17: 288-296. PMID 9427762 DOI: 10.1093/Emboj/17.1.288  0.875
1998 García-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, Levy DE, Durbin JE. The Role of Interferon in Influenza Virus Tissue Tropism Journal of Virology. 72: 8550-8558. DOI: 10.1128/Jvi.72.11.8550-8558.1998  0.632
1998 Staczek J, Gilleland HE, Gilleland LB, Harty RN, García-Sastre A, Engelhardt OG, Palese P. A Chimeric Influenza Virus Expressing an Epitope of Outer Membrane Protein F of Pseudomonas aeruginosa Affords Protection against Challenge with P. aeruginosa in a Murine Model of Chronic Pulmonary Infection Infection and Immunity. 66: 3990-3994. DOI: 10.1128/iai.66.8.3990-3994.1998  0.527
1997 Palese P, Zavala F, Muster T, Nussenzweig RS, García-Sastre A. Development of novel influenza virus vaccines and vectors. The Journal of Infectious Diseases. S45-9. PMID 9240694 DOI: 10.1086/514175  0.678
1997 Wang P, Palese P, O'Neill RE. The NPI-1/NPI-3 (karyopherin alpha) binding site on the influenza a virus nucleoprotein NP is a nonconventional nuclear localization signal. Journal of Virology. 71: 1850-1856. PMID 9032315 DOI: 10.1128/Jvi.71.3.1850-1856.1997  0.445
1997 Wang P, Palese P, O'Neill RE. The NPI-1/NPI-3 (karyopherin α) binding site on the influenza A virus nucleoprotein NP is a nonconventional nuclear localization signal Journal of Virology. 71: 1850-1856. PMID 9032315  0.334
1996 Palese P, Zheng H, Engelhardt OG, Pleschka S, García-Sastre A. Negative-strand RNA viruses: genetic engineering and applications. Proceedings of the National Academy of Sciences of the United States of America. 93: 11354-8. PMID 8876139 DOI: 10.1073/Pnas.93.21.11354  0.509
1996 Palese P, Roizman B. Genetic engineering of viruses and of virus vectors: a preface. Proceedings of the National Academy of Sciences of the United States of America. 93: 11287. PMID 8876127 DOI: 10.1073/Pnas.93.21.11287  0.522
1996 Murata K, García-Sastre A, Tsuji M, Rodrigues M, Rodriguez D, Rodriguez JR, Nussenzweig RS, Palese P, Esteban M, Zavala F. Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. Cellular Immunology. 173: 96-107. PMID 8871605 DOI: 10.1006/Cimm.1996.0255  0.439
1996 Wolff T, O'Neill RE, Palese P. Interaction cloning of NS1-I, a human protein that binds to the nonstructural NS1 proteins of influenza A and B viruses Journal of Virology. 70: 5363-5372. PMID 8764047 DOI: 10.1128/Jvi.70.8.5363-5372.1996  0.616
1996 Zheng H, Palese P, Garcia-Sastre A. Nonconserved nucleotides at the 3′ and 5′ ends of an influenza A virus RNA play an important role in viral RNA replication Virology. 217: 242-251. PMID 8599209 DOI: 10.1006/Viro.1996.0111  0.482
1996 Pleschka S, Jaskunas R, Engelhardt OG, Zürcher T, Palese P, García-Sastre A. A plasmid-based reverse genetics system for influenza A virus. Journal of Virology. 70: 4188-4192. DOI: 10.1128/Jvi.70.6.4188-4192.1996  0.63
1995 O'Neill RE, Palese P. NPI-1, the human homolog of SRP-1, Interacts with influenza virus nucleoprotein Virology. 206: 116-125. PMID 7831767 DOI: 10.1016/S0042-6822(95)80026-3  0.617
1995 Barclay WS, Palese P. Influenza B viruses with site-specific mutations introduced into the HA gene Journal of Virology. 69: 1275-1279. PMID 7815505 DOI: 10.1128/Jvi.69.2.1275-1279.1995  0.636
1995 Palese P. Genetic engineering of infectious negative-strand RNA viruses Trends in Microbiology. 3: 123-125. PMID 7613750 DOI: 10.1016/S0966-842X(00)88897-6  0.34
1995 Harty RN, Palese P. Mutations within noncoding terminal sequences of model RNAs of Sendai virus: Influence on reporter gene expression Journal of Virology. 69: 5128-5131. PMID 7609082 DOI: 10.1128/Jvi.69.8.5128-5131.1995  0.424
1995 Harty RN, Palese P. Measles virus phosphoprotein (P) requires the NH2- and COOH-terminal domains for interactions with the nucleoprotein (N) but only the COOH terminus for interactions with itself Journal of General Virology. 76: 2863-2867. PMID 7595396 DOI: 10.1099/0022-1317-76-11-2863  0.301
1995 O'Neill RE, Jaskunas R, Blobel G, Palese P, Moroianu J. Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import Journal of Biological Chemistry. 270: 22701-22704. PMID 7559393 DOI: 10.1074/Jbc.270.39.22701  0.529
1995 Garcia-Sastre A, Palese P. Influenza virus vectors Biologicals. 23: 171-178. PMID 7546660 DOI: 10.1006/Biol.1995.0028  0.7
1995 Isobe H, Moran T, Li S, Young A, Nathenson S, Palese P, Bona C. Presentation by a major histocompatibility complex class I molecule of nucleoprotein peptide expressed in two different genes of an influenza virus transfectant. The Journal of Experimental Medicine. 181: 203-13. PMID 7528768 DOI: 10.1084/Jem.181.1.203  0.499
1995 García-Sastre A, Palese P. The cytoplasmic tail of the neuraminidase protein of influenza A virus does not play an important role in the packaging of this protein into viral envelopes Virus Research. 37: 37-47. PMID 7483820 DOI: 10.1016/0168-1702(95)00017-K  0.592
1995 Muster T, Ferko B, Klima A, Purtscher M, Trkola A, Schulz P, Grassauer A, Engelhardt OG, García-Sástre A, Palese P. Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. Journal of Virology. 69: 6678-6686. DOI: 10.1128/Jvi.69.11.6678-6686.1995  0.607
1994 Percy N, Barclay WS, García-Sastre A, Palese P. Expression of a foreign protein by influenza A virus Journal of Virology. 68: 4486-4492. PMID 8207822 DOI: 10.1128/Jvi.68.7.4486-4492.1994  0.604
1994 Zurcher T, Luo G, Palese P. Mutations at palmitylation sites of the influenza virus hemagglutinin affect virus formation Journal of Virology. 68: 5748-5754. PMID 8057456 DOI: 10.1128/Jvi.68.9.5748-5754.1994  0.606
1994 O'Neill RE, Palese P. Cis-acting signals and trans-acting factors involved in influenza virus RNA synthesis Infectious Agents and Disease. 3: 77-84. PMID 7812658  0.51
1994 García-Sastre A, Percy N, Barclay W, Palese P. Introduction of foreign sequences into the genome of influenza A virus Developments in Biological Standardization. 82: 237-246. PMID 7525392  0.56
1994 Muster T, Guinea R, Trkola A, Purtscher M, Klima A, Steindl F, Palese P, Katinger H. Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS Journal of Virology. 68: 4031-4034. PMID 7514684 DOI: 10.1128/Jvi.68.6.4031-4034.1994  0.643
1994 Li X, Palese P. Characterization of the polyadenylation signal of influenza virus RNA Journal of Virology. 68: 1245-1249. PMID 7507179 DOI: 10.1128/Jvi.68.2.1245-1249.1994  0.536
1994 Muster T, Guinea R, Trkola A, Purtscher M, Klima A, Steindl F, Palese P, Katinger H. Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS. Journal of Virology. 68: 4031-4034. DOI: 10.1128/jvi.68.6.4031-4034.1994  0.367
1994 García-Sastre A, Muster T, Barclay WS, Percy N, Palese P. Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus. Journal of Virology. 68: 6254-6261. DOI: 10.1128/Jvi.68.10.6254-6261.1994  0.676
1993 Li S, Schulman J, Itamura S, Palese P. Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus. Journal of Virology. 67: 6667-73. PMID 8411368 DOI: 10.1128/Jvi.67.11.6667-6673.1993  0.636
1993 Piccone ME, Fernandez-Sesma A, Palese P. Mutational analysis of the influenza virus vRNA promoter Virus Research. 28: 99-112. PMID 8317146 DOI: 10.1016/0168-1702(93)90129-B  0.453
1993 Garcia-Sastre A, Palese P. Genetic manipulation of negative-strand RNA virus genomes Annual Review of Microbiology. 47: 765-790. PMID 8257115 DOI: 10.1146/Annurev.Mi.47.100193.004001  0.48
1993 Guangxiang L, Jeffrey C, Palese P. Alterations of the stalk of the influenza virus neuraminidase: deletions and insertions Virus Research. 29: 141-153. PMID 8212856 DOI: 10.1016/0168-1702(93)90055-R  0.617
1993 Li S, Rodrigues M, Rodriguez D, Rodriguez JR, Esteban M, Palese P, Nussenzweig RS, Zavala F. Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proceedings of the National Academy of Sciences of the United States of America. 90: 5214-8. PMID 7685119 DOI: 10.1073/Pnas.90.11.5214  0.589
1993 Li S, Polonis V, Isobe H, Zaghouani H, Guinea R, Moran T, Bona C, Palese P. Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1. Journal of Virology. 67: 6659-6666. DOI: 10.1128/Jvi.67.11.6659-6666.1993  0.655
1992 Luo G, Palese P. Genetic analysis of influenza virus Current Opinion in Genetics and Development. 2: 77-81. PMID 1633429 DOI: 10.1016/S0959-437X(05)80326-0  0.595
1992 Luo G, Bergmann M, Garcia-Sastre A, Palese P. Mechanism of attenuation of a chimeric influenza A/B transfectant virus Journal of Virology. 66: 4679-4685. PMID 1629948 DOI: 10.1128/Jvi.66.8.4679-4685.1992  0.669
1992 Li X, Palese P. Mutational analysis of the promoter required for influenza virus virion RNA synthesis Journal of Virology. 66: 4331-4338. PMID 1602547 DOI: 10.1128/Jvi.66.7.4331-4338.1992  0.435
1992 Klotz FW, Orlandi PA, Reuter G, Cohen SJ, Haynes JD, Schauer R, Howard RJ, Palese P, Miller LH. Binding of Plasmodium falciparum 175-kilodalton erythrocyte binding antigen and invasion of murine erythrocytes requires N-acetylneuraminic acid but not its O-acetylated form. Molecular and Biochemical Parasitology. 51: 49-54. PMID 1565137 DOI: 10.1016/0166-6851(92)90199-T  0.343
1992 Li SQ, Schulman JL, Moran T, Bona C, Palese P. Influenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes. Journal of Virology. 66: 399-404. PMID 1370088 DOI: 10.1128/Jvi.66.1.399-404.1992  0.637
1992 Bergmann M, Garcia-Sastre A, Palese P. Transfection-mediated recombination of influenza A virus Journal of Virology. 66: 7576-7580. PMID 1279208 DOI: 10.1128/Jvi.66.12.7576-7580.1992  0.643
1991 Muster T, Subbarao EK, Enami M, Murphy BR, Palese P. An influenza A virus containing influenza B virus 5' and 3' noncoding regions on the neuraminidase gene is attenuated in mice. Proceedings of the National Academy of Sciences of the United States of America. 88: 5177-81. PMID 2052599 DOI: 10.1073/Pnas.88.12.5177  0.693
1991 Luo G, Luytjes W, Enami M, Palese P. The Polyadenylation Signal of Influenza Virus RNA Involves a Stretch of Uridines Followed by the RNA Duplex of the Panhandle Structure Journal of Virology. 65: 2861-2867. PMID 2033659 DOI: 10.1128/Jvi.65.6.2861-2867.1991  0.413
1991 Lin DA, Roychoudhury S, Palese P, Clay WC, Fuller FJ. Evolutionary relatedness of the predicted gene product of RNA segment 2 of the tick-borne Dhori virus and the PB1 polymerase gene of influenza viruses. Virology. 182: 1-7. PMID 2024457 DOI: 10.1016/0042-6822(91)90641-N  0.569
1991 Enami M, Palese P. High-Efficiency Formation of Influenza Virus Transfectants Journal of Virology. 65: 2711-2713. PMID 2016777 DOI: 10.1128/Jvi.65.5.2711-2713.1991  0.607
1991 Fitch WM, Leiter JME, Li X, Palese P. Positive Darwinian evolution in human influenza A viruses Proceedings of the National Academy of Sciences of the United States of America. 88: 4270-4274. PMID 1840695 DOI: 10.1073/Pnas.88.10.4270  0.587
1991 Enami M, Sharma G, Benham C, Palese P. An influenza virus containing nine different RNA segments Virology. 185: 291-298. PMID 1833874 DOI: 10.1016/0042-6822(91)90776-8  0.543
1990 Luytjes W, Krystal M, Enami M, Parvin JD, Palese P. Amplification, expression, and packaging of foreign gene by influenza virus. Cell. 59: 1107-13. PMID 2598262 DOI: 10.1016/0092-8674(89)90766-6  0.607
1990 Enami M, Luytjes W, Krystal M, Palese P. Introduction of site-specific mutations into the genome of influenza virus Proceedings of the National Academy of Sciences of the United States of America. 87: 3802-3805. PMID 2339122 DOI: 10.1073/Pnas.87.10.3802  0.611
1990 Leiter JM, Agrawal S, Palese P, Zamecnik PC. Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides. Proceedings of the National Academy of Sciences of the United States of America. 87: 3430-4. PMID 2333292 DOI: 10.1073/Pnas.87.9.3430  0.657
1990 Huang TS, Palese P, Krystal M. Determination of influenza virus proteins required for genome replication Journal of Virology. 64: 5669-5673. PMID 2214032 DOI: 10.1128/Jvi.64.11.5669-5673.1990  0.684
1989 Yamashita M, Krystal M, Palese P. Comparison of the three large polymerase proteins of influenza A, B, and C viruses Virology. 171: 458-466. PMID 2763462 DOI: 10.1016/0042-6822(89)90615-6  0.601
1989 Li R, Palese P, Krystal M. Complementation and analysis of an NP mutant of influenza virus Virus Research. 12: 97-111. PMID 2650474 DOI: 10.1016/0168-1702(89)90057-9  0.439
1989 Leiter JME, Krystal M, Palese P. Expression of antisense RNA fails to inhibit influenza virus replication Virus Research. 14: 141-159. PMID 2481910 DOI: 10.1016/0168-1702(89)90035-X  0.583
1989 Vlasak R, Muster T, Lauro AM, Powers JC, Palese P. Influenza C virus esterase: analysis of catalytic site, inhibition, and possible function. Journal of Virology. 63: 2056-2062. DOI: 10.1128/Jvi.63.5.2056-2062.1989  0.628
1989 Parvin JD, Palese P, Honda A, Ishihama A, Krystal M. Promoter analysis of influenza virus RNA polymerase. Journal of Virology. 63: 5142-5152. DOI: 10.1128/Jvi.63.12.5142-5152.1989  0.51
1988 Yamashita M, Krystal M, Palese P. Evidence that the matrix protein of influenza C virus is coded for by a spliced mRNA Journal of Virology. 62: 3348-3355. PMID 3404579 DOI: 10.1128/Jvi.62.9.3348-3355.1988  0.562
1988 Vlasak R, Luytjes W, Spaan W, Palese P. Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses Proceedings of the National Academy of Sciences of the United States of America. 85: 4526-4529. PMID 3380803 DOI: 10.1073/Pnas.85.12.4526  0.619
1988 Yamashita M, Krystal M, Fitch WM, Palese P. Influenza B virus evolution: Co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses Virology. 163: 112-122. PMID 3267218 DOI: 10.1016/0042-6822(88)90238-3  0.637
1988 Vlasak R, Luytjes W, Leider J, Spaan W, Palese P. The E3 protein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity Journal of Virology. 62: 4686-4690. PMID 3184275 DOI: 10.1128/Jvi.62.12.4686-4690.1988  0.387
1988 Greenspan D, Palese P, Krystal M. Two nuclear location signals in the influenza virus NS1 nonstructural protein Journal of Virology. 62: 3020-3026. PMID 2969057 DOI: 10.1128/Jvi.62.8.3020-3026.1988  0.601
1988 Leider JM, Palese P, Smith FI. Determination of the mutation rate of a retrovirus Journal of Virology. 62: 3084-3091. PMID 2841464 DOI: 10.1128/Jvi.62.9.3084-3091.1988  0.456
1988 Makoto Y, Krystal M, Palese P. The matrix protein of influenza C virus is coded for by a spliced mRNA Virus Research. 11: 42. DOI: 10.1016/0168-1702(88)90179-7  0.534
1988 Vlasak R, Palese P. Receptor destroying activities of RNA viruses: Identification of the catalytic site of the influenza C virus esterase Virus Research. 11: 7. DOI: 10.1016/0168-1702(88)90111-6  0.575
1987 Norton GP, Tanaka T, Tobita K, Nakada S, Buonagurio DA, Greenspan D, Krystal M, Palese P. Infectious influenza A and B virus variants with long carboxyl terminal deletions in the NS1 polypeptides. Virology. 156: 204-13. PMID 3811235 DOI: 10.1016/0042-6822(87)90399-0  0.592
1987 Vlasak R, Krystal M, Nacht M, Palese P. The influenza c virus glycoprotein (HE) exhibits receptor-binding (hemagglutinin) and receptor-destroying (esterase) activities Virology. 160: 419-425. PMID 3660588 DOI: 10.1016/0042-6822(87)90013-4  0.646
1987 Smith GL, Levin JZ, Palese P, Moss B. Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses Virology. 160: 336-345. PMID 3310381 DOI: 10.1016/0042-6822(87)90004-3  0.675
1987 Hsu MT, Parvin JD, Gupta S, Krystal M, Palese P. Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle. Proceedings of the National Academy of Sciences of the United States of America. 84: 8140-4. PMID 2446318 DOI: 10.1073/Pnas.84.22.8140  0.454
1986 Smith FI, Parvin JD, Palese P. Detection of single base substitutions in influenza virus RNA molecules by denaturing gradient gel electrophoresis of RNA-RNA or DNA-RNA heteroduplexes Virology. 150: 55-64. PMID 3952989 DOI: 10.1016/0042-6822(86)90265-5  0.364
1986 Parvin JD, Moscona A, Pan WT, Leider JM, Palese P. Measurement of the mutation rates of animal viruses: Influenza A virus and poliovirus type 1 Journal of Virology. 59: 377-383. PMID 3016304 DOI: 10.1128/Jvi.59.2.377-383.1986  0.595
1986 Krystal M, Li R, Lyles D, Pavlakis G, Palese P. Expression of the three influenza virus polymerase proteins in a single cell allows growth complementation of viral mutants. Proceedings of the National Academy of Sciences of the United States of America. 83: 2709-13. PMID 3010315 DOI: 10.1073/Pnas.83.8.2709  0.457
1986 Nakada S, Graves PN, Palese P. The influenza C virus NS gene: evidence for a spliced mRNA and a second NS gene product (NS2 protein) Virus Research. 4: 263-273. PMID 2943090 DOI: 10.1016/0168-1702(86)90005-5  0.535
1986 Buonagurio DA, Nakada S, Fitch WM, Palese P. Epidemiology of influenza C virus in man: Multiple evolutionary lineages and low rate of change Virology. 153: 12-21. PMID 2943076 DOI: 10.1016/0042-6822(86)90003-6  0.539
1986 Buonagurio DA, Nakada S, Parvin JD, Krystal M, Palese P, Fitch WM. Evolution of human influenza A viruses over 50 years: Rapid, uniform rate of change in NS gene Science. 232: 980-982. PMID 2939560 DOI: 10.1126/Science.2939560  0.408
1986 Parvin JD, Moscona A, Pan WT, Leider JM, Palese P. Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1. Journal of Virology. 59: 377-383. DOI: 10.1128/jvi.59.2.377-383.1986  0.523
1985 Buonagurio DA, Nakada S, Desselberger U, Krystal M, Palese P. Noncumulative sequence changes in the hemagglutinin genes of influenza C virus isolates. Virology. 146: 221-32. PMID 3855244 DOI: 10.1016/0042-6822(85)90006-6  0.609
1985 Greenspan D, Krystal M, Nakada S, Arnheiter H, Lyles DS, Palese P. Expression of influenza virus NS2 nonstructural protein in bacteria and localization of NS2 in infected eucaryotic cells. Journal of Virology. 54: 833-43. PMID 2987535 DOI: 10.1128/Jvi.54.3.833-843.1985  0.689
1985 Nakada S, Graves PN, Desselberger U, Creager RS, Krystal M, Palese P. Influenza C virus RNA 7 codes for a nonstructural protein. Journal of Virology. 56: 221-226. DOI: 10.1128/Jvi.56.1.221-226.1985  0.533
1985 Palese P, Nakada S, Buonagurio D, Desselberger U, Krystal M. Non-cumulative changes in the hemagglutinin genes of influenza C viruses Virus Research. 3: 79. DOI: 10.1016/0168-1702(85)90409-5  0.532
1985 Palese P, Greenspan D, Nakada S, Krystal M. Nuclear localization of NS1 and NS2 proteins in influenza a virus infected cells : Identification of nuclear signal sequences Virus Research. 3: 40. DOI: 10.1016/0168-1702(85)90331-4  0.559
1985 Krystal M, Li R, Lyles D, Palese P. Complementation of influenza virus ts mutants using cell lines constitutively expressing influenza virus polymerase proteins Virus Research. 3: 17. DOI: 10.1016/0168-1702(85)90287-4  0.675
1984 Nakada S, Creager RS, Krystal M, Aaronson RP, Palese P. Influenza C virus hemagglutinin: Comparison with influenza A and B virus hemagglutinins Journal of Virology. 50: 118-124. PMID 6699942 DOI: 10.1128/Jvi.50.1.118-124.1984  0.632
1984 Nakada S, Creager RS, Krystal M, Palese P. Complete nucleotide sequence of the influenza C/California/78 virus nucleoprotein gene Virus Research. 1: 433-441. PMID 6532006 DOI: 10.1016/0168-1702(84)90001-7  0.601
1984 Townsend ARM, Skehel JJ, Taylor PM, Palese P. Recognition of influenza A virus nucleoprotein by an H-2-restricted cytotoxic T-cell clone Virology. 133: 456-459. PMID 6200990 DOI: 10.1016/0042-6822(84)90413-6  0.591
1984 Laski FA, Belagaje R, Hudziak RM, Capecchi MR, Norton GP, Palese P, RajBhandary UL, Sharp PA. Synthesis of an ochre suppressor tRNA gene and expression in mammalian cells. The Embo Journal. 3: 2445-52. PMID 6096120 DOI: 10.1002/J.1460-2075.1984.Tb02154.X  0.389
1984 Buonagurio DA, Krystal M, Palese P, DeBorde DC, Maassab HF. Analysis of an influenza A virus mutant with a deletion in the NS segment. Journal of Virology. 49: 418-425. DOI: 10.1128/Jvi.49.2.418-425.1984  0.612
1983 Krystal M, Buonagurio D, Young JF, Palese P. Sequential mutations in the NS genes of influenza virus field strains Journal of Virology. 45: 547-554. PMID 6834468 DOI: 10.1128/Jvi.45.2.547-554.1983  0.562
1983 Parvin JD, Young JF, Palese P. Nonsense mutations affecting the lengths of the NS1 nonstructural proteins of influenza A virus isolates Virology. 128: 512-517. PMID 6612993 DOI: 10.1016/0042-6822(83)90280-5  0.538
1983 Young JF, Desselberger U, Palese P, Ferguson B, Shatzman AR, Rosenberg M. Efficient expression of influenza virus NS1 nonstructural proteins in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America. 80: 6105-9. PMID 6310615 DOI: 10.1073/Pnas.80.19.6105  0.575
1983 Young JF, Capecchi M, Laski FA, RajBhandary UL, Sharp PA, Palese P. Measurement of suppressor transfer RNA activity. Science (New York, N.Y.). 221: 873-5. PMID 6308765 DOI: 10.1126/Science.6308765  0.457
1983 Krystal M, Young JF, Palese P, Wilson IA, Skehel JJ, Wiley DC. Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains. Proceedings of the National Academy of Sciences of the United States of America. 80: 4527-31. PMID 6192436 DOI: 10.1073/Pnas.80.14.4527  0.612
1983 Graves PN, Schulman JL, Young JF, Palese P. Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: Unmasking of cross-reactive HA2 determinants Virology. 126: 106-116. PMID 6189287 DOI: 10.1016/0042-6822(83)90465-8  0.65
1982 Palese P, Young JF. Variation of influenza A, B, and C viruses Science. 215: 1468-1474. PMID 7038875 DOI: 10.1126/Science.7038875  0.592
1982 Krystal M, Elliott RM, Benz EW, Young JF, Palese P. Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes. Proceedings of the National Academy of Sciences of the United States of America. 79: 4800-4. PMID 6956892 DOI: 10.1073/Pnas.79.15.4800  0.582
1981 Baez M, Zazra JJ, Elliott RM, Young JF, Palese P. Nucleotide sequence of the influenza A/duck/Alberta/60/76 virus NS RNA: conservation of the NS1/NS2 overlapping gene structure in a divergent influenza virus RNA segment. Virology. 113: 397-402. PMID 6927848 DOI: 10.1016/0042-6822(81)90166-5  0.528
1981 Mitsialis SA, Young JF, Palese P, Guntaka RV. An avian tumor virus promoter directs expression of plasmid genes in Escherichia coli Gene. 16: 217-225. PMID 6282693 DOI: 10.1016/0378-1119(81)90078-0  0.349
1981 Palese P. Epidemiology of influenza Osterreichische Arztezeitung. 36: 367-369.  0.536
1980 Baez M, Taussig R, Zazra JJ, Young JF, Palese P, Reisfeld A, Skalka AM. Complete nucleotide sequence of the influenza A/PR/8/34 virus NS gene and comparison with the NS genes of the A/Udorn/72 and A/FPV/Rostock/34 strains Nucleic Acids Research. 8: 5845-5858. PMID 7465426 DOI: 10.1093/Nar/8.23.5845  0.563
1980 Palese P. New biochemical techniques for the characterization of viruses to assist the epidemiologist Journal of Infectious Diseases. 142: 633-635. PMID 7441023 DOI: 10.1093/Infdis/142.4.633  0.384
1980 Baez M, Palese P, Kilbourne ED. Gene composition of high-yielding influenza vaccine strains obtained by recombination Journal of Infectious Diseases. 141: 362-365. PMID 7365284 DOI: 10.1093/Infdis/141.3.362  0.459
1980 Desselberger U, Racaniello VR, Zazra JJ, Palese P. The 3' and 5'-terminal sequences of influenza A, B and C virus RNA segments are highly conserved and show partial inverted complementarity Gene. 8: 315-328. PMID 7358274 DOI: 10.1016/0378-1119(80)90007-4  0.725
1980 Brand C, Palese P. Sequential passage of influenza virus in embryonated eggs or tissue culture: Emergence of mutants Virology. 107: 424-433. PMID 6256942 DOI: 10.1016/0042-6822(80)90309-8  0.616
1980 Young JF, Elliott RM, Berkowitz EM, Palese P. Mechanisms of genetic variation in human influenza viruses. Annals of the New York Academy of Sciences. 354: 135-41. PMID 6164327 DOI: 10.1111/J.1749-6632.1980.Tb27963.X  0.572
1980 Lubeck MD, Schulman JL, Palese P. Antigenic variants of influenza viruses: Marked differences in the frequencies of variants selected with different monoclonal antibodies Virology. 102: 458-462. PMID 6154380 DOI: 10.1016/0042-6822(80)90114-2  0.57
1980 Palese P, Racaniello VR, Desselberger U, Young J, Baez M. Genetic structure and genetic variation of influenza viruses Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences. 288: 299-305. PMID 6103546  0.747
1980 Palese P. Genetic variation of human influenza viruses Trends in Biochemical Sciences. 5. DOI: 10.1016/0968-0004(80)90064-X  0.535
1979 Racaniello VR, Palese P. Isolation of influenza C virus recombinants Journal of Virology. 32: 1006-1014. PMID 513198 DOI: 10.1128/Jvi.32.3.1006-1014.1979  0.749
1979 Young JF, Desselberger U, Palese P. Evolution of human influenza a viruses in nature: Sequential mutations in the genomes of new H1N1 isolates Cell. 18: 73-83. PMID 509526 DOI: 10.1016/0092-8674(79)90355-6  0.553
1979 Lubeck MD, Palese P, Schulman JL. Nonranom association of parental genes in influenza A virus recombinants Virology. 95: 269-274. PMID 442543 DOI: 10.1016/0042-6822(79)90430-6  0.373
1979 Racaniello VR, Palese P. Influenza B virus genome: assignment of viral polypeptides to RNA segments Journal of Virology. 29: 361-373. PMID 430594 DOI: 10.1128/Jvi.29.1.361-373.1979  0.761
1979 Young JF, Palese P. Evolution of human influenza A viruses in nature: Recombination contributes to genetic variation of H1N1 strains Proceedings of the National Academy of Sciences of the United States of America. 76: 6547-6551. PMID 293742 DOI: 10.1073/Pnas.76.12.6547  0.566
1978 Lubeck MD, Schulman JL, Palese P. Susceptibility of influenza A virus to amantadine is influenced by the gene coding for M protein Journal of Virology. 28: 710-716. PMID 731792 DOI: 10.1128/Jvi.28.3.710-716.1978  0.404
1978 Desselberger U, Palese P. Molecular weights of RNA segments of influenza A and B viruses Virology. 88: 394-399. PMID 695330 DOI: 10.1016/0042-6822(78)90297-0  0.541
1978 Nakajima K, Desselberger U, Palese P. Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950 Nature. 274: 334-339. PMID 672956 DOI: 10.1038/274334A0  0.545
1978 Moss B, Keith JM, Gershowitz A, Ritchey MB, Palese P. Common sequence at the 5' ends of the segmented RNA genomes of influenza A and B viruses Journal of Virology. 25: 312-318. PMID 621778 DOI: 10.1128/Jvi.25.1.312-318.1978  0.434
1978 Desselberger U, Nakajima K, Alfino P, Pedersen FS, Haseltine WA, Hannoun C, Palese P. Biochemical evidence that "new" influenza virus strains in nature may arise by recombination (reassortment). Proceedings of the National Academy of Sciences of the United States of America. 75: 3341-5. PMID 277933 DOI: 10.1073/Pnas.75.7.3341  0.554
1978 Moss B, Keith JM, Gershowitz A, Ritchey MB, Palese P. Common Sequence at the 5′ Ends of the Segmented RNA Genomes of Influenza A and B Viruses Journal of Virology. 25: 312-318. DOI: 10.1128/jvi.25.1.312-318.1978  0.357
1977 Palese P, Ritchey MB. Live attenuated influenza virus vaccines strains with temperature-sensitive defects in P3 protein and nucleoprotein Virology. 78: 183-191. PMID 860398 DOI: 10.1016/0042-6822(77)90090-3  0.671
1977 Ritchey MB, Palese P. Identification of the defective genes in three mutant groups of influenza virus Journal of Virology. 21: 1196-1204. PMID 850307 DOI: 10.1128/Jvi.21.3.1196-1204.1977  0.504
1977 Palese P, Ritchey MB, Schulman JL. P1 and P3 proteins of influenza virus are required for complementary RNA synthesis Journal of Virology. 21: 1187-1195. PMID 850306 DOI: 10.1128/Jvi.21.3.1187-1195.1977  0.486
1977 Palese P. The genes of influenza virus Cell. 10: 1-10. PMID 837439 DOI: 10.1016/0092-8674(77)90133-7  0.696
1977 Ritchey MB, Palese P, Schulman JL. Differences in protein patterns of influenza A viruses Virology. 76: 122-128. PMID 835225 DOI: 10.1016/0042-6822(77)90289-6  0.66
1977 Palese P, Ritchey MB, Schulman JL. Mapping of the influenza virus genome II. Identification of the P1, P2, and P3 genes Virology. 76: 114-121. PMID 835223 DOI: 10.1016/0042-6822(77)90288-4  0.543
1977 Palese P, Ritchey MB. Polyacrylamide gel electrophoresis of the RNAs of new influenza virus strains: an epidemiological tool Developments in Biological Standardization. 39: 411-415. PMID 604123  0.555
1977 Schulman JL, Palese P. Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells Journal of Virology. 24: 170-176. PMID 561860 DOI: 10.1128/Jvi.24.1.170-176.1977  0.68
1976 Palese P, Schulman JL. Differences in RNA patterns of influenza A viruses Journal of Virology. 17: 876-884. PMID 1255862 DOI: 10.1128/Jvi.17.3.876-884.1976  0.554
1976 Palese P, Schulman JL. Mapping of the influenza virus genome: Identification of the hemagglutinin and the neuraminidase genes Proceedings of the National Academy of Sciences of the United States of America. 73: 2142-2146. PMID 1064882 DOI: 10.1073/Pnas.73.6.2142  0.561
1976 Ritchey MB, Palese P, Schulman JL. Mapping of the influenza virus genome. III. Identification of genes coding for nucleoprotein, membrane protein, and nonstructural protein Journal of Virology. 20: 307-313. PMID 985644 DOI: 10.1128/Jvi.20.1.307-313.1976  0.563
1976 Schulman JL, Palese P. Selection and identification of influenza virus recombinants of defined genetic composition Journal of Virology. 20: 248-254. PMID 978791 DOI: 10.1128/Jvi.20.1.248-254.1976  0.449
1976 Palese P, Compans RW. Inhibition of influenza virus replication in tissue culture by 2 deoxy 2,3 dehydro N trifluoroacetylneuraminic acid (FANA): mechanism of action Journal of General Virology. 33: 159-163. PMID 978183 DOI: 10.1099/0022-1317-33-1-159  0.633
1976 Palese P, Schulman JL. RNA pattern of 'Swine' influenza virus isolated from man is similar to those of other swine influenza viruses Nature. 263: 528-530. PMID 972705 DOI: 10.1038/263528A0  0.7
1976 Palese P, Ritchey MB, Schulman JL, Kilbourne ED. Genetic composition of a high yielding influenza A virus recombinant: a vaccine strain against 'swine' influenza Science. 194: 334-335. PMID 968486 DOI: 10.1126/Science.968486  0.63
1976 Ritchey MB, Palese P. In vitro translation of influenza virus messenger RNAs Virology. 72: 410-420. PMID 948868 DOI: 10.1016/0042-6822(76)90170-7  0.52
1976 Ritchey MB, Palese P, Kilbourne ED. RNAs of influenza A, B, and C viruses Journal of Virology. 18: 738-744. PMID 944790 DOI: 10.1128/Jvi.18.2.738-744.1976  0.637
1975 Schulman JL, Palese P. Susceptibility of different strains of influenza a virus to the inhibitory effects of 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA) Virology. 63: 98-104. PMID 1167433 DOI: 10.1016/0042-6822(75)90374-8  0.645
1975 Krug RM, Ueda M, Palese P. Temperature sensitive mutants of influenza WSN virus defective in virus specific RNA synthesis Journal of Virology. 16: 790-796. PMID 1165595 DOI: 10.1128/Jvi.16.4.790-796.1975  0.438
1974 Palese P, Tobita K, Ueda M, Compans RW. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase Virology. 61: 397-410. PMID 4472498 DOI: 10.1016/0042-6822(74)90276-1  0.614
1974 Compans RW, Meier-Ewert H, Palese P. Assembly of lipid-containing viruses Journal of Supramolecular Structure. 2: 496-511. PMID 4437183 DOI: 10.1002/Jss.400020234  0.446
1974 Palese P, Schulman JL, Bodo G, Meindl P. Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA) Virology. 59: 490-498. PMID 4364826 DOI: 10.1016/0042-6822(74)90458-9  0.647
1974 Meindl P, Bodo G, Palese P, Schulman J, Tuppy H. Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. Virology. 58: 457-63. PMID 4362431 DOI: 10.1016/0042-6822(74)90080-4  0.734
1974 Palese P, Schulman J. Isolation and characterization of influenza virus recombinants with high and low neuraminidase activity. Use of 2-(3′-methoxyphenyl)-N-acetylneuraminic acid to identify cloned populations Virology. 57: 227-237. PMID 4131955 DOI: 10.1016/0042-6822(74)90123-8  0.614
1974 Palese P, Schulman JL, Tobita K. The requirement of neuraminidase activity for influenza virus replication Behring Inst.Mitt.. 11-18.  0.604
1973 Palese P, Bucher D, Kilbourne ED. Applications of a synthetic neuraminidase substrate Applied Microbiology. 25: 195-201. PMID 4121031 DOI: 10.1128/Aem.25.2.195-201.1973  0.503
1972 Palese P, McAuslan BR. Virus-associated DNase: Endonuclease in a polyhedral cytoplasmic deoxyvirus Virology. 49: 319-321. PMID 4625022 DOI: 10.1016/S0042-6822(72)80036-9  0.574
1972 Palese P, Koch G. Degradation of single- and double-stranded RNA by frog virus 3 Proceedings of the National Academy of Sciences of the United States of America. 69: 698-701. PMID 4335069 DOI: 10.1073/Pnas.69.3.698  0.457
1971 Meindl P, Bodo G, Lindner J, Palese P. Influence of 2-Deoxy-2,3-dehydro-N-acetylneuraminic Acid on Myxovirus-neuraminidases and the Replication of Influenza- and Newcastle Disease Virus Zeitschrift Fur Naturforschung - Section B Journal of Chemical Sciences. 26: 792-797. PMID 4399278 DOI: 10.1515/Znb-1971-0812  0.601
1971 Bodo G, Palese P, Horak I, Hilfenhaus J, Siegert W, Jungwirth C. Interferon action: effect on the formation of poxvirus specific polysomes and viral RNA. Zeitschrift Fur Naturforschung. Teil B, Chemie, Biochemie, Biophysik, Biologie Und Verwandte Gebiete. 25: 1164-70. PMID 4394875 DOI: 10.1515/Znb-1970-1020  0.348
1971 Bodo G, Palese P, Lindner J. Activity of Mouse Interferon in Human Cells Proceedings of the Society For Experimental Biology and Medicine. 137: 1392-1395. PMID 4333098 DOI: 10.3181/00379727-137-35796  0.371
1970 Palese P, Bodo G, Tuppy H. Quantitative determination of neuraminidase-active foci in cell monolayer cultures infected with influenza or newcastle disease virus. Journal of Virology. 6: 556-8. PMID 5497902 DOI: 10.1128/Jvi.6.4.556-558.1970  0.724
1969 Tuppy H, Palese P. A chromogenic substrate for the investigation of neuraminidases. Febs Letters. 3: 72-75. PMID 11946972 DOI: 10.1016/0014-5793(69)80100-6  0.577
1968 Tuppy H, Palese P. [Pig kidney neuraminidase: purification and properties]. Hoppe-Seyler's Zeitschrift FüR Physiologische Chemie. 349: 1169-78. PMID 5706143  0.541
1968 Tuppy H, Palese P. Neuraminidase aus Schweinenieren Reinigung und Eigenschaften Hoppe-Seyler's Zeitschrift Fur Physiologische Chemie. 349: 1169-1178. DOI: 10.1515/Bchm2.1968.349.2.1169  0.576
Show low-probability matches.